<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Nanomedicine</journal-id><journal-id journal-id-type="iso-abbrev">Int J Nanomedicine</journal-id><journal-id journal-id-type="publisher-id">ijn</journal-id><journal-id journal-id-type="pmc">intjnano</journal-id><journal-title-group><journal-title>International Journal of Nanomedicine</journal-title></journal-title-group><issn pub-type="ppub">1176-9114</issn><issn pub-type="epub">1178-2013</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7778679</article-id><article-id pub-id-type="publisher-id">275258</article-id><article-id pub-id-type="doi">10.2147/IJN.S275258</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Improved in vitro and in vivo Anti-<italic>Candida albicans</italic> Activity of <italic>Cymbopogon nardus</italic> Essential Oil by Its Incorporation into a Microemulsion System</article-title><alt-title alt-title-type="running-authors">Gaspar de Toledo et al</alt-title><alt-title alt-title-type="running-title">Gaspar de Toledo et al</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6276-0150</contrib-id><name><surname>Gaspar de Toledo</surname><given-names>Luciani</given-names></name><xref ref-type="aff" rid="aff0001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>dos Santos Ramos</surname><given-names>Matheus Aparecido</given-names></name><xref ref-type="aff" rid="aff0001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bento da Silva</surname><given-names>Patr&#x000ed;cia</given-names></name><xref ref-type="aff" rid="aff0002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rodero</surname><given-names>Camila Fernanda</given-names></name><xref ref-type="aff" rid="aff0003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>de S&#x000e1; Gomes</surname><given-names>Veridiana</given-names></name><xref ref-type="aff" rid="aff0001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Noronha da Silva</surname><given-names>Anderson</given-names></name><xref ref-type="aff" rid="aff0001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pavan</surname><given-names>Fernando Rog&#x000e9;rio</given-names></name><xref ref-type="aff" rid="aff0001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9617-9858</contrib-id><name><surname>da Silva</surname><given-names>Isabel Cristiane</given-names></name><xref ref-type="aff" rid="aff0001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7217-0840</contrib-id><name><surname>Bombarda Oda</surname><given-names>Fernando</given-names></name><xref ref-type="aff" rid="aff0004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3207-4891</contrib-id><name><surname>Flumignan</surname><given-names>Danilo Luis</given-names></name><xref ref-type="aff" rid="aff0005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gonzaga dos Santos</surname><given-names>Andr&#x000e9;</given-names></name><xref ref-type="aff" rid="aff0004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chorilli</surname><given-names>Marlus</given-names></name><xref ref-type="aff" rid="aff0003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gottardo de Almeida</surname><given-names>Margarete Teresa</given-names></name><xref ref-type="aff" rid="aff0006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bauab</surname><given-names>Ta&#x000ed;s Maria</given-names></name><xref ref-type="aff" rid="aff0001"><sup>1</sup></xref><xref ref-type="corresp" rid="an0001"/></contrib><aff id="aff0001"><label>1</label>School of Pharmaceutical Sciences, Department of Biological Sciences, <institution>S&#x000e3;o Paulo State University (UNESP)</institution>, <addr-line>S&#x000e3;o Paulo</addr-line>, <country>Brazil</country></aff><aff id="aff0002"><label>2</label>Department of Genetics and Morphology, <institution>University of Bras&#x000ed;lia (UnB), Institute of Biological Sciences</institution>, <addr-line>Bras&#x000ed;lia</addr-line>, <addr-line>Distrito Federal</addr-line>, <country>Brazil</country></aff><aff id="aff0003"><label>3</label>School of Pharmaceutical Sciences, Department of Drug and Medicines, <institution>S&#x000e3;o Paulo State University (UNESP)</institution>, <addr-line>S&#x000e3;o Paulo</addr-line>, <country>Brazil</country></aff><aff id="aff0004"><label>4</label>School of Pharmaceutical Sciences, Department of Natural Active Principles and Toxicology, <institution>S&#x000e3;o Paulo State University (UNESP)</institution>, <addr-line>S&#x000e3;o Paulo</addr-line>, <country>Brazil</country></aff><aff id="aff0005"><label>5</label><institution>S&#x000e3;o Paulo Federal Institute of Education, Science and Technology (IFSP)</institution>, <addr-line>S&#x000e3;o Paulo</addr-line>, <country>Brazil</country></aff><aff id="aff0006"><label>6</label><institution>Faculty of Medicine of S&#x000e3;o Jos&#x000e9; do Rio Preto (FAMERP), Department of Infectious Diseases</institution>, <addr-line>S&#x000e3;o Jos&#x000e9; do Rio Preto</addr-line>, <addr-line>S&#x000e3;o Paulo</addr-line>, <country>Brazil</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: Ta&#x000ed;s Maria Bauab <institution>School of Pharmaceutical Sciences, Department of Biological Sciences, S&#x000e3;o Paulo State University (UNESP)</institution>, <addr-line>Campus Araraquara</addr-line>, <addr-line>S&#x000e3;o Paulo</addr-line><addr-line>14800-903</addr-line>, <country>Brazil</country><phone>Tel +55-16-3301-6955</phone><fax>Fax +55-16-3322-0073</fax> Email tais.bauab@unesp.br</corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>15</volume><fpage>10481</fpage><lpage>10497</lpage><history><date date-type="received"><day>04</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>01</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Gaspar de Toledo et al.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Gaspar de Toledo et al.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><abstract><sec id="s2001"><title>Purpose</title><p>Vulvovaginal candidiasis (VVC) is an opportunistic fungal infection that adversely affects a woman&#x02019;s health, due to unpleasant symptoms, therapeutic challenges, and the emergence of resistant strains. The association of natural products and nanotechnology is important to improve the antifungal potential of medicinal plants. We aimed to evaluate the in vitro and in vivo anti-<italic>Candida albicans</italic> activity of unloaded (EO) and loaded (ME+EO) essential oil of <italic>Cymbopogon nardus</italic> in the microemulsion (ME).</p></sec><sec id="s2002"><title>Methods</title><p>The chemical analysis of the EO was performed by gas chromatography-mass spectrometry. The ME and ME+EO were characterized by scattering, zeta potential, polarized light microscopy, rheological assays, mucoadhesiveness and transmission electronic microscopy. The in vitro antifungal activity of the EO and ME+EO were evaluated by microdilution technique. The toxicity of EO and ME+EO was analyzed on human cell line HaCat and using alternative model assay with <italic>Artemia salina</italic>. The experimental in vivo VVC was performed in female mice (C57BL/6).</p></sec><sec id="s2003"><title>Results</title><p>The main compounds of the EO were found to be citronellal, geranial, geraniol, citronellol, and neral. The formulations exhibited suitable size, homogeneity, negative charge, isotropic behavior, highly organized structure, and pseudoplastic behavior, for vaginal application. TEM photomicrographs showed possible EO droplets inside the spherical structures. The EO, when loaded into the ME, exhibited an improvement in its antifungal action against <italic>C. albicans</italic>. The EO was not toxic against brine shrimp nauplii. An in vivo VVC assay showed that the use of the ME significantly improved the action of the EO, since only the ME+EO promoted the eradication of the fungal vaginal infection on the third day of treatment.</p></sec><sec id="s2004"><title>Conclusion</title><p>The EO and ME+EO are promising alternatives for the control of fungal infections caused by <italic>C. albicans</italic>, once the use of nanotechnology significantly improved the antifungal action of the EO, especially in an in vivo model of VVC.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>nanostructured lipid system</kwd><kwd>citronella</kwd><kwd>vulvovaginal candidiasis</kwd><kwd>therapeutic treatment</kwd></kwd-group><counts><fig-count count="6"/><table-count count="18"/><ref-count count="77"/><page-count count="17"/></counts></article-meta></front><body><sec sec-type="intro" id="s0001"><title>Introduction</title><p>Vulvovaginal candidiasis (VVC) is the second most common cause of vaginitis after bacterial vaginosis, which highlights it as an important women&#x02019;s health issue.<xref rid="cit0001" ref-type="bibr">1</xref> According to Denning et al, 2018, 75% of women have had VVC at least once during their lives and recurrent episodes may occur, leading to recurrent vulvovaginal candidiasis (RVVC). Although VVC is not a lethal disease, quality of life is drastically affected, both socially and economically, especially in cases of RVVC, which is considered the chronic phase of the disease.<xref rid="cit0003" ref-type="bibr">3</xref></p><p><italic>Candida albicans</italic> is the species responsible for over 90% of VVC cases, followed by <italic>C. tropicalis, C. glabrata, C. krusei, C. parapsilosis</italic>, and <italic>C. lusitaniae</italic>.<xref rid="cit0001" ref-type="bibr">1</xref> VVC is common in women following antibiotic treatment, in pregnant women, and in women undergoing hormone replacement.<xref rid="cit0002" ref-type="bibr">2</xref> The symptoms of VVC include pain, vulvar erythema, abrasions, pruritus, and a &#x0201c;curd-like&#x0201d; or watery vaginal discharge.<xref rid="cit0004" ref-type="bibr">4</xref></p><p>The limitations of antifungal therapy, such as high cost, toxicity, drug interactions, and low drug bioavailability, are factors that contribute to the inefficiency of conventional antifungals, as represented by azole, polyenic, and echinocandin compounds.<xref rid="cit0005" ref-type="bibr">5</xref> In addition, the emergence of drug-resistant strains has stimulated the search for new antifungal agents with different mechanisms of action.<xref rid="cit0006" ref-type="bibr">6</xref></p><p>Plants are an important therapeutic possibility for treating fungal infections. The essential oil (EO) of the leaves of <italic>Cymbopogon nardus</italic> (L.) Rendle (citronella) is applied in cosmetic and perfumery industries and is used as an insect repellent. Geraniol, citral, citronellal and citronellol, the main chemical compounds from this EO, have various biological activities.<xref rid="cit0007" ref-type="bibr">7&#x02013;9</xref> Toledo et al (2016) reported the antifungal activity of the EO of <italic>C. nardus</italic> against standard and clinical strains of <italic>C. albicans, C. krusei, C. glabrata, C. tropicalis</italic>, and <italic>C. parapsilosis</italic>. Moreover, the EO was able to inhibit the main virulence factors, such as hyphal formation, of <italic>C. albicans</italic> and the mature biofilm of <italic>Candida</italic> species. The advantages presented by plant extracts have stimulated research on the application of alternative methods to improve the antifungal activity of plant derivatives, such as the use of nanotechnology, which allows the enhancement of biological activity, the control of drug release, and a reduction of side effects.<xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0012" ref-type="bibr">12</xref></p><p>Microemulsions (MEs) are potential nanostructured drug delivery systems. MEs present characteristics such as transparent emulsions, in which an oil is dispersed in an aqueous medium (or vice versa), containing a surfactant associated with an appropriate co-surfactant. The system is a thermodynamically stable system and shows internal phase with droplets of nanometer order, thus improving drug solubilization.<xref rid="cit0012" ref-type="bibr">12</xref>,<xref rid="cit0013" ref-type="bibr">13</xref></p><p>Studies involving the use of natural products and nanotechnology in in vivo VVC models have been employed due to economic reasons, accessibility, and the anatomical similarity of the animal to humans. These studies have shown promising antifungal potential of the tested products, with remarkable results.<xref rid="cit0014" ref-type="bibr">14</xref>,<xref rid="cit0015" ref-type="bibr">15</xref></p><p>The antifungal potential of <italic>C. nardus</italic> EO shown in previous study<xref rid="cit0010" ref-type="bibr">10</xref> and the advantages of using nanostructured drug delivery systems, such as MEs, has stimulated the development of alternative antifungal agents. Furthermore, citronella EO production occurs on a large scale, which facilitates its use as a raw material for the production of herbal medicines. Furthermore, EO extraction by hydrodistillation shows advantages over the use of organic solvents for the production of plant extracts, as it takes into consideration green chemistry principles,<xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0017" ref-type="bibr">17</xref> reducing the environmental impact and the cost of the process.<xref rid="cit0018" ref-type="bibr">18</xref>,<xref rid="cit0019" ref-type="bibr">19</xref></p><p>In this context, the aim of this study was to evaluate the possible improvement of the anti-<italic>C. albicans</italic> activity of the EO of <italic>C. nardus</italic> when loaded in a microemulsion (ME+EO). The mode of action was assessed by analyzing sorbitol and ergosterol interaction. The human cell line, HaCat, and an alternative model of <italic>Artemia salina</italic> were used to evaluate toxicity. Furthermore, in vivo VVC treatment was assessed in mice, in order to investigate the efficacy of vaginal administration of EO and ME+EO for the control of vaginal fungal infection.</p></sec><sec id="s0002"><title>Materials and Methods</title><sec id="s0002-s2001"><title>Plant Material</title><p>The leaves of <italic>C. nardus</italic> (L.) Rendle were collected from April to June 2016, in the morning, in the Garden of Toxic and Medicinal Plants: &#x0201c;Profa. Dra. C&#x000e9;lia Cebrian de Ara&#x000fa;jo Reis&#x0201d; (S&#x000e3;o Paulo State University [UNESP], Araraquara, S&#x000e3;o Paulo, Brazil). A voucher specimen (HRCB-60752) was deposited at Herbarium Rioclarense of the Institute of Biosciences (UNESP, Rio Claro, S&#x000e3;o Paulo, Brazil). This work was approved by the National System for the Management of Genetic Heritage and Associated Traditional Knowledge (SisGen) under license numbers A2B917A and AF35617/CNPJ 48.031.918/0001-24.</p></sec><sec id="s0002-s2002"><title>Extraction of Essential Oil from <italic>C. nardus</italic></title><p>EO was extracted from fresh leaves of <italic>C. nardus</italic> (150 g) by hydrodistillation, using a Clevenger-type apparatus attached to a round bottom flask (3 L) with 1500 mL of deionized water (4 h). Residual water in the EO was separated from the sample by freezing. The yield of the EO was 0.7% (w/w). EO samples were stored at &#x02212;20&#x000ba;C until used for chemical analysis and biological assays.</p></sec><sec id="s0002-s2003"><title>Gas Chromatographic Analysis of Essential Oil from <italic>C. nardus</italic></title><sec id="s0002-s2003-s3001"><title>Gas Chromatography-Mass Spectrometry</title><p>Chemical analysis of EO from <italic>C. nardus</italic> was performed by gas chromatography-mass spectrometry (GC-MS), using a Shimadzu<sup>&#x000ae;</sup> GCMS-QP2010S gas chromatograph (mass detector: electron impact ionization; mass quadrupole analyzer), fitted with an Rtx-5ms capillary column (30 m x 0.25 mm, film thickness 0.25 &#x000b5;m; Shimadzu<sup>&#x000ae;</sup>, Kyoto, Japan). Helium was used as the carrier gas at a flow rate of 1.00 mL/min (58.8 kPa) and a linear velocity of 36.8 cm/s. The oven temperature program was 60&#x02013;246&#x000ba;C at 3&#x000ba;C/min for 62 min, the injector temperature was 240&#x000ba;C, the injection volume was 1 &#x000b5;L, the splitting ratio was 1:20, the ionization energy was 50 eV (280&#x000ba;C), and the transfer line temperature was 250&#x000ba;C. The EO was solubilized in hexane (chromatographic grade) at a ratio of 1:100 (v/v) and standard solutions were injected at concentrations of 5.0, 4.0, 3.0, 2.0, 1.0, 0.5, and 0.25 mg/mL. EO compounds were identified by comparing acquired mass spectra (from chromatogram peaks) with reference spectra of the National Institute of Standards and Technology mass-spectral library version 2.0 (2012) and data from the literature. Arithmetic retention indices<xref rid="cit0020" ref-type="bibr">20</xref> were calculated as previously described (Adams, 2007), by linear interpolation relative to the retention times (<italic>t</italic><sub>R</sub>) of a series of <italic>n</italic>-alkanes (C8&#x02013;C20). These values were compared with a published retention indices.<xref rid="cit0021" ref-type="bibr">21</xref> Relative amounts of EO components were calculated using the chromatogram peak area normalization method. The quantification of major EO compounds was performed using an analytical curve (external standard method), considering the commercial purity of each of the following standards (Sigma-Aldrich, St Louis, MO, USA): citronellal (95.0%), citronellol (95.0%), and geraniol (95.0%).</p></sec><sec id="s0002-s2003-s3002"><title>Microemulsion: Phase Diagram Development</title><p>MEs were prepared according to the method of Bonif&#x000e1;cio et al<xref rid="cit0022">22</xref> (2015). MEs consisted of grape seed oil as the oil phase (OP), polyoxyethylene (23) lauryl ether (Brij35<sup>&#x000ae;</sup>) + soy phosphatidylcholine (2:1) as the surfactant (S), and phosphate-buffered saline (PBS) as the aqueous phase (AP).</p><p>The phase diagram development generated 36 formulations, mixing different concentrations of the constituents, but maintaining constant oil phase and surfactant proportions. The mixtures were sonicated (Q500; QSonica, Newtown, CT, USA) with a potency of 500 watts and a 20% amplitude, in discontinuous mode for 7 min, with an interval of 30 s in an ice bath every 59 s. The EO (2000 &#x000b5;g/mL) was loaded to the ME (ME+EO) by sonication for 30 s.</p></sec></sec><sec id="s0002-s2004"><title>Microemulsion Characterization</title><sec id="s0002-s2004-s3001"><title>Mean Diameter and Polydispersity Index</title><p>The mean diameter of the ME was performed by photon correlation using a dynamic laser scattering instrument (Brookhaven Instruments, Holtsville, NY, USA). The hydrodynamic radius of the colloidal particles of the Einstein-Stokes equation (<xref ref-type="disp-formula" rid="m0001">Eq. [1</xref>]) was calculated as follows:
<disp-formula-group><disp-formula id="m0001"><label>(1)</label><alternatives><graphic xlink:href="IJN-15-10481-e0001.jpg" position="float" orientation="portrait"/><tex-math id="M1">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{D}} = {{{\rm{K}}.{\rm{T}}} \over {6.\rm{\pi} .\rm{\eta} .{\rm{Rh}}}}$$
\end{document}</tex-math></alternatives></disp-formula></disp-formula-group></p><p>where D is the diffusion coefficient of the particles, K is the Boltzmann&#x02019;s constant (1.3807 &#x000d7; 10<sup>&#x02212;23</sup> NmK<sup>&#x02212;1</sup>), T is the absolute temperature (293.15 K), &#x003c0;&#x000a0;= 3.141592, &#x003b7; is the viscosity (1.002 &#x000d7; 10<sup>&#x02212;3</sup> NM<sup>&#x02212;2s</sup>), and Rh is the hydrodynamic radius.</p><p>The ME (without EO) and ME+EO were analyzed in the analysis chamber with a laser beam crossing throughout the dispersion. The system was maintained at 25&#x000b0;C, with a laser wavelength of 532 nm and the refractive index for each sample was analyzed according to the index observed. Ten determinations of the mean diameter and the polydispersity index (PDI) of droplets of each sample were performed (n = 3). This assay was performed after 24 h (T0) and 3 months (T3) of samples preparation in order to verify stability of formulations and possible alterations in particle diameter.</p></sec><sec id="s0002-s2004-s3002"><title>Zeta Potential</title><p>Zeta potential (ZP) was determined by assessing electrophoretic mobility using a Zetasizer Nano NS instrument (Malvern Instruments, Malvern, UK). Analyses were performed 24 h after ME preparation. The samples were diluted 1:10 in ultra-purified water, placed in the electrophoretic cell, and 3 determinations of surface potential were performed for each sample (ME and ME+EO). The mean and standard deviation were calculated. Zeta potential analyses were carried out after 24 h (T0) and 3 months (T3) of samples preparation in order to verify stability of formulations.</p></sec><sec id="s0002-s2004-s3003"><title>Polarized Light Microscopy</title><p>ME and ME+EO were placed on a glass slide, covered with a cover slip, and analyzed by polarized light microscopy (PLM; BX41 coupled with QColor3 Section; Olympus, Tokyo, Japan) at room temperature (25 &#x000b1; 0.5&#x000b0;C).</p></sec><sec id="s0002-s2004-s3004"><title>Continuous Shear Rheology</title><p>An AR2000 pressure-controlled rheometer (TA Instruments, New Castle, DE, USA) was used for rheometry assays. Analyses were performed in triplicate, using cone/plate (40 mm diameter at a 52 &#x003bc;m gap) and plate/plate (40 mm diameter at a 200 &#x003bc;m gap) geometry at 37.0 &#x000b1; 0.1&#x000b0;C. A controlled shear rate was used, ranging from 0 to 100 s<sup>&#x02212;1</sup>, during 120 s (each step) with 10 s interval between curves. The shear was minimal and equilibrated 1 min prior to each analysis and the formulations were applied to the bottom plate. The consistency index and the flow index were determined using <xref ref-type="disp-formula" rid="m0002">eq 2</xref> for a quantitative analysis of flow behavior.
<disp-formula-group><disp-formula id="m0002"><label>(2)</label><alternatives><graphic xlink:href="IJN-15-10481-e0002.jpg" position="float" orientation="portrait"/><tex-math id="M2">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$$\tau = {\ }\kappa .{\gamma ^{\rm{\eta }}}$$
\end{document}</tex-math></alternatives></disp-formula></disp-formula-group></p><p>where <italic>&#x003c4;</italic> is the shear stress, <italic>&#x003b3;</italic> is the shear rate, <italic>&#x003ba;</italic> is the consistency index, and <italic>&#x003b7;</italic> is the flow index.<xref rid="cit0023" ref-type="bibr">23</xref></p></sec><sec id="s0002-s2004-s3005"><title>Oscillatory Rheology</title><p>Oscillatory rheometry was performed using the same parameters (rheometer, geometries, and temperature, 37.0 &#x000b1; 0.1&#x000b0;C, to simulate the in vivo environment) as described for continuous shear rheometry. To establish the viscoelastic region of the formulations, a stress scan was performed, resulting in an ideal frequency condition ranging from 1 to 10 Hz. To perform a quantitative analysis of the dependence of G&#x02032; on the frequency, the exponent <italic>n</italic> and <italic>S</italic> were calculated using <xref ref-type="disp-formula" rid="m0003">eq 3</xref>, which indicates the structure of the systems obtained.
<disp-formula-group><disp-formula id="m0003"><label>(3)</label><alternatives><graphic xlink:href="IJN-15-10481-e0003.jpg" position="float" orientation="portrait"/><tex-math id="M3">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$$G{^{\prime}} = S.{{\rm{\omega }}^n}$$
\end{document}</tex-math></alternatives></disp-formula></disp-formula-group></p><p>where <italic>G&#x02032;</italic> is the storage modulus, <italic>&#x003c9;</italic> is the oscillatory frequency, <italic>S</italic> is the formulation strength, and <italic>n</italic> is the viscoelastic exponent.<xref rid="cit0023" ref-type="bibr">23</xref></p></sec><sec id="s0002-s2004-s3006"><title>Mucoadhesion Force</title><p>A TA.XTplus texture analyzer (Stable Micro Systems, Surrey, UK) was used, in the adhesion test mode, to evaluate the detachment force between porcine vaginal mucosa and the formulations tested (ME; ME+EO). Two mm thickness of porcine vaginal mucosa was fixed to the cylindrical probe (10 mm diameter) of the equipment. The temperature during the analyses was controlled at 37 &#x000b1; 0.5&#x000b0;C. ME or ME+EO samples were added to small containers below the probe (same direction). The probe was lowered (constant rate, 1 mm/s) until the mucosa had direct contact (60 s) with the formulations (ME; ME+EO), without force employed during this period.</p><p>At a constant velocity (0.5 mm/s), the probe was lifted until the mucosa detached from the formulations. The force required to detach the formulation from the mucosa was calculated from the force versus time curve. Five replicates were performed.<xref rid="cit0024" ref-type="bibr">24</xref></p></sec><sec id="s0002-s2004-s3007"><title>Transmission Electron Microscopy</title><p>The morphology and structure of the ME and ME+EO were visualized by transmission electron microscopy (TEM), using a JEM-100CX2 transmission electron microscope (JEOL, Tokyo, Japan), with an acceleration of 100 kV. The samples were diluted in water (1:10 v/v), coated on a copper grid (200 mesh), and dried at room temperature (25 &#x000b1; 0.5&#x000b0;C). Images were acquired at 50,000&#x000d7; magnification.<xref rid="cit0025" ref-type="bibr">25</xref></p></sec></sec><sec id="s0002-s2005"><title>Antifungal Activity</title><sec id="s0002-s2005-s3001"><title>Fungal Strains</title><p><italic>Candida albicans</italic> ATCC 10231 (CA-ATCC) and one clinical isolate (CAV &#x02013; human vaginal origin) were used in this study. The clinical strain was donated from the Microbiology Laboratory of the Medicine School in Sao Jose do Rio Preto (FAMERP) for the purpose of scientific research after written consent from the donors. The Human Research Ethics Committee of FAMERP approved the use of this strain (project identification code 152/20066, December 2006).</p></sec><sec id="s0002-s2005-s3002"><title>Determination of Minimal Inhibitory Concentration</title><p>The minimal inhibitory concentrations (MICs) of EO and ME+EO were determined using a microplate dilution technique, according to protocol M27-A3,<xref rid="cit0026" ref-type="bibr">26</xref> with some modifications. Roswell Park Memorial Institute (RPMI) 1640 medium (0.1 mL) was added to a 96-well microplate and was inoculated with 0.1 mL of a fungal suspension containing 2.5 &#x000d7; 10<sup>3</sup> colony-forming units (CFU)/mL. EO and ME+EO were tested at concentrations ranging from 7.8 to 500 &#x000b5;g/mL. Amphotericin B (AmB, Sigma-Aldrich) and fluconazole (Sigma-Aldrich) were used as positive controls. Culture medium, yeast growth, EO, ME+EO, ME, and solvent were used as additional (sterility) controls. Microplates were incubated at 37&#x000b0;C for 48 h. After incubation, 20 &#x000b5;L of an aqueous solution of 2% 2,3,5-triphenyltetrazolium chloride was added and the plates were incubated at 37&#x000b0;C for 2 h.<xref rid="cit0027" ref-type="bibr">27</xref> All tests were performed in triplicate.</p></sec><sec id="s0002-s2005-s3003"><title>Determination of Minimal Fungicidal Concentration</title><p>To determine the minimum fungicidal concentration (MFC), an aliquot from each well that showed antifungal activity was plated on a Petri dish containing Sabouraud dextrose agar (DIFCO; BD Biosciences, Franklin Lakes, NJ, USA). The tests were carried out in triplicate. MFC was defined as the lowest concentration of EO and ME+EO that prevented visible growth on the solid medium.<xref rid="cit0014" ref-type="bibr">14</xref></p></sec><sec id="s0002-s2005-s3004"><title>Ergosterol Assay</title><p>The binding of EO and ME+EO to membrane ergosterol in <italic>C. albicans</italic> was evaluated according to the method described by Peixoto et al<xref rid="cit0028">28</xref> (2017). Microplates were prepared according to protocol M27-A3,<xref rid="cit0026" ref-type="bibr">26</xref> with some modifications. EO and ME+EO were evaluated at concentrations ranging from 5000 &#x003bc;g/mL to 2.44 &#x003bc;g/mL. <italic>C. albicans</italic> (ATCC 102331 and CAV) suspensions (10<sup>3</sup> cells/mL) were prepared (100 &#x000b5;L) in RPMI 1640 medium supplemented with 200 &#x003bc;g/mL exogenous ergosterol. Medium without exogenous ergosterol was used as a control. Microplates were incubated at 35&#x000b0;C and readings were performed after 2 d.</p></sec><sec id="s0002-s2005-s3005"><title>Sorbitol Assay</title><p>To evaluate the interactions of EO and ME+EO with the fungal cell wall, microplates were prepared as described in the MIC determination experiments, according to protocol M27-A3,<xref rid="cit0026" ref-type="bibr">26</xref> with some modifications. EO and ME-EO were added to microplates at concentrations ranging from 1,000 &#x003bc;g/mL to 0.48 &#x003bc;g/mL. One hundred microliters of <italic>C. albicans</italic> (ATCC 102331 and CAV) suspensions (10<sup>3</sup> cells/mL), prepared in RPMI 1640 medium supplemented with 0.8 M sorbitol, were added. Medium without sorbitol was used as a control. Microplates were incubated at 35&#x000b0;C and readings were performed after 2 and 7 d.<xref rid="cit0028" ref-type="bibr">28</xref></p></sec></sec><sec id="s0002-s2006"><title>Toxicity Assays</title><sec id="s0002-s2006-s3001"><title>HaCat Cell Line</title><p>Cytotoxicity assays were performed in the HaCat human keratinocyte cell line obtained from Banco de c&#x000e9;lulas do Rio de Janeiro (BCRJ: 0341), according to a previously described protocol<xref rid="cit0029" ref-type="bibr">29</xref> using the resazurin reduction method. Cells (2.5 &#x000d7; 10<sup>4</sup> cells/mL) were added to a 96-well microplate (Costar, Cambridge, MA, USA) for 24 h. After this process, cells were treated with EO (from 7.8 to 1000 &#x003bc;g/mL) or ME+EO (from 0.1 to 30 &#x003bc;g/mL). After 24 h of incubation, the medium was removed and 50 mL of resazurin, diluted to 0.01% in DMEM, was added. The microplates were then incubated at 37&#x000b0;C for 3 h. Fluorescence was measured using a Synergy H1 microplate reader (BioTek, Winooski, VT, USA) using an excitation wavelength of 530 nm and an emission wavelength of 590 nm. Untreated cells (viable cells) were used as negative controls, cells treated with 5 &#x000b5;g/mL doxorubicin (Sigma-Aldrich) were used as positive controls (dead cells), and 1% DMSO was used as the vehicle control. Assays were performed in triplicate. IC<sub>50</sub> values, which represent the concentrations required to inhibit 50% of cells, were calculated by regression analysis from a calibration curve.</p></sec><sec id="s0002-s2006-s3002"><title>Artemia Salina Model</title><p>Brine shrimp cysts of <italic>Artemia salina</italic>, for use in the conventional Artemia test, were acquired from <italic>Artemia salina</italic> of RN, Natal, Brazil, produced by Flagner Sores de Souza. In vitro toxicity was assessed using an <italic>Artemia salina</italic> (brine shrimp) model, according to a previously described method (Parra et al<xref rid="cit0030">30</xref>, 2001), with some modifications. Briefly, 25 mg of <italic>A. salina</italic> cysts was incubated for 24 h in artificial saline water consisting of 23 g of NaCl, 11 g of MgCl<sub>2</sub>.6H<sub>2</sub>O, 4 g of Na<sub>2</sub>SO<sub>4</sub>, 1.3 g of CaCl<sub>2</sub>.H<sub>2</sub>O, and 0.7 g of KCl dissolved in 1000 mL of distilled water. An oxygen pump was placed in the saline water and a light was coupled on top of the container to keep the temperature at 25&#x000b0;C during the experiment. After 24 h of incubation, the nauplii were fed with 0.6 g of <italic>Saccharomyces cerevisiae</italic> and incubated for another 24 h.</p><p>The next day, a suspension of nauplii (10&#x02013;15 organisms/well) in a volume of 100 &#x003bc;L of saline water was added to a 96-well microplate. In a separate microplate, a serial dilution of the compounds was prepared with concentrations of EO and ME+EO ranging from 0.2 to 1000 &#x000b5;g/mL. The controls consisted of untreated nauplii (negative control), 2% DMSO (vehicle control), and potassium dichromate (positive control). After 24 h of treatment, the plate was examined under a binocular stereoscopic microscope and the number of dead nauplii in each well was counted to calculate the median lethal concentration (LC<sub>50</sub>). Larvae were considered dead if they did not exhibit any internal or external movement during several seconds of observation.</p></sec></sec><sec id="s0002-s2007"><title>In vivo VVC Study in a Mouse Model</title><p>In vivo VVC assays were performed in a mouse model following the recommended guidelines of the Ethics Principles in Animal Experimentation of the Ethics Committee on the Use of Animals in Research, CEUA School of Pharmaceutical Sciences of Araraquara, UNESP, S&#x000e3;o Paulo State, Brazil, after approval protocol number 56/2016. Animals were purchased from Centro Multidisciplinar para Investiga&#x000e7;&#x000e3;o Biol&#x000f3;gica na &#x000c1;rea da Ci&#x000ea;ncia em Animais de Laborat&#x000f3;rio, CEMIB, Unicamp, Campinas, S&#x000e3;o Paulo State, Brazil.</p><p>Female C57BL/6 mice (n = 56) at 8&#x02013;10 weeks of age, weighing 20&#x02013;25 g, were used for these experiments. For environmental adaptation, the animals remained in the experimental room for 4 weeks before starting the assay. During the entire experiment, the animals were kept in polypropylene boxes (50 &#x000d7; 30 &#x000d7; 20 cm), maintained with adequate temperature and ventilation and an alternating 12/12 h light/dark cycle.</p><p>The different experimental groups are listed in <xref rid="t0001" ref-type="table">Table 1</xref>. <italic>C. albicans</italic> ATCC 10231 was used in this study. Initially, the pseudoestrus hormonal phase was induced in mice by subcutaneous administration (0.1 mL) of estradiol (Sigma-Aldrich) at a concentration of 2 mg/mL, at 6 and 3 days prior to infection (initial day). On the initial day, 20 &#x003bc;L of a <italic>C. albicans</italic> suspension containing 2.5 &#x000d7; 10<xref rid="cit0008" ref-type="bibr">8</xref> cells/mL was inoculated into the vaginal environment. At day 1, treatments (20 &#x003bc;L administered/animal) were initialized (once/day) and additional treatments were administered on days 3, 5, and 7. On days 2, 4, and 6, estradiol administration was continued to maintain the pseudoestrous phase. On days 2, 4, 6, and 8, vaginal lavages were performed with PBS.<xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0031" ref-type="bibr">31</xref> The infection was monitored by individual vaginal lavage of the mice (70 &#x003bc;L of sterile PBS), with repeated aspiration, shaking, and subsequent plating on Sabouraud agar + chloramphenicol (Acumedia, Lansing, MI, USA) to determine the number CFUs. After 48 h of incubation of the agar plates at 37&#x000b0;C, the colonies were counted. Colony counts are expressed as log CFU/mL.<xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0031" ref-type="bibr">31</xref> The animals were euthanized in a CO<sub>2</sub> chamber.<table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1</label><caption><p>Specification and Treatments Used in the in vivo VVC Study</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Specification</th><th rowspan="1" colspan="1">Treatments</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Negative Infection</td><td rowspan="1" colspan="1">Sterile PBS</td></tr><tr><td rowspan="1" colspan="1">Positive Infection</td><td rowspan="1" colspan="1">Sterile PBS</td></tr><tr><td rowspan="1" colspan="1">Positive control</td><td rowspan="1" colspan="1">20 &#x000b5;L of commercial cream<break/>(amphotericin-B + tetracycline)</td></tr><tr><td rowspan="1" colspan="1">Solvent control</td><td rowspan="1" colspan="1">DMSO 10%</td></tr><tr><td rowspan="1" colspan="1">EO</td><td rowspan="1" colspan="1">20 &#x000b5;L of EO (2.0 mg/mL)</td></tr><tr><td rowspan="1" colspan="1">ME+EO</td><td rowspan="1" colspan="1">20 &#x000b5;L of ME+EO (2.0 mg/mL)</td></tr><tr><td rowspan="1" colspan="1">ME control</td><td rowspan="1" colspan="1">20 &#x000b5;L of ME (without EO)</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><bold>Notes:</bold> Treatments were performed with the administration of 20 &#x000b5;L of each treatment once per day.</p><p><bold>Abbreviations:</bold> EO, essential oil of <italic>C. nardus</italic>; ME+EO, loaded essential oil in the microemulsion; ME, microemulsion (without EO).</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="s0002-s2008"><title>Statistical Analysis</title><p>Results are reported as mean &#x000b1; standard deviation (SD). Statistical analyses were performed with Prism 7.00 software (GraphPad, San Diego, CA, USA) using a two-way ANOVA, with a post-hoc Tukey&#x02019;s test for multiple comparisons. A Student&#x02019;s <italic>t</italic> test was used to compare means between only two groups. It was considered to be statistically significant if <italic>p</italic> &#x0003c; 0.05.</p></sec></sec><sec id="s0003"><title>Results and Discussion</title><sec id="s0003-s2001"><title>Chemical Composition of <italic>Cymbopogon nardus</italic> Essential Oil</title><p>The chemical profile (qualitative and quantitative composition) of the EO from <italic>C. nardus</italic>, as determined by GC-MS, is shown in <xref rid="t0002" ref-type="table">Table 2</xref>. The following oxygen-containing monoterpenes (89.93%) were the major constituents: citronellal (27.34%), geraniol (23.21%), geranial (13.37%), citronellol (12.49%), and neral (10.31%). These monoterpenes are biosynthetically related and are derived from geranyl diphosphate.<xref rid="cit0032" ref-type="bibr">32</xref><table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2</label><caption><p>Chemical Composition of <italic>C. nardus</italic> Essential Oil</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Retention Time</th><th rowspan="1" colspan="1">Compound Name</th><th rowspan="1" colspan="1">AI <sup>a</sup><break/>(Calculated)</th><th rowspan="1" colspan="1">AI<sup>b</sup><break/>(Literature)</th><th rowspan="1" colspan="1">Concentration (%)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">5.555</td><td rowspan="1" colspan="1">5-methyl-5-hexen-2-one</td><td rowspan="1" colspan="1">915</td><td rowspan="1" colspan="1">895</td><td rowspan="1" colspan="1">0.06</td></tr><tr><td rowspan="1" colspan="1">7.7</td><td rowspan="1" colspan="1"><italic>&#x003b2;</italic> -myrcene</td><td rowspan="1" colspan="1">992</td><td rowspan="1" colspan="1">988</td><td rowspan="1" colspan="1">0.11</td></tr><tr><td rowspan="1" colspan="1">8.105</td><td rowspan="1" colspan="1"><italic>n-octanal</italic></td><td rowspan="1" colspan="1">1005</td><td rowspan="1" colspan="1">998</td><td rowspan="1" colspan="1">0.11</td></tr><tr><td rowspan="1" colspan="1">9.02</td><td rowspan="1" colspan="1">D-limonene</td><td rowspan="1" colspan="1">1030</td><td rowspan="1" colspan="1">1024</td><td rowspan="1" colspan="1">3.21</td></tr><tr><td rowspan="1" colspan="1">9.295</td><td rowspan="1" colspan="1"><italic>cis</italic>-ocimene</td><td rowspan="1" colspan="1">1037</td><td rowspan="1" colspan="1">1032</td><td rowspan="1" colspan="1">0.24</td></tr><tr><td rowspan="1" colspan="1">9.68</td><td rowspan="1" colspan="1"><italic>trans</italic>-ocimene</td><td rowspan="1" colspan="1">1048</td><td rowspan="1" colspan="1">1044</td><td rowspan="1" colspan="1">0.15</td></tr><tr><td rowspan="1" colspan="1">9.91</td><td rowspan="1" colspan="1">bergamal</td><td rowspan="1" colspan="1">1054</td><td rowspan="1" colspan="1">1051</td><td rowspan="1" colspan="1">0.55</td></tr><tr><td rowspan="1" colspan="1">10.605</td><td rowspan="1" colspan="1">not identified</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">0.33</td></tr><tr><td rowspan="1" colspan="1">11.670</td><td rowspan="1" colspan="1"><italic>&#x003b2;</italic>-linalool</td><td rowspan="1" colspan="1">1102</td><td rowspan="1" colspan="1">1095</td><td rowspan="1" colspan="1">0.79</td></tr><tr><td rowspan="1" colspan="1">11.93</td><td rowspan="1" colspan="1"><italic>&#x003b1;</italic>-pinene oxide</td><td rowspan="1" colspan="1">1108</td><td rowspan="1" colspan="1">1099</td><td rowspan="1" colspan="1">0.07</td></tr><tr><td rowspan="1" colspan="1">12.14</td><td rowspan="1" colspan="1"><italic>trans</italic>-rose oxide</td><td rowspan="1" colspan="1">1113</td><td rowspan="1" colspan="1">1122</td><td rowspan="1" colspan="1">0.12</td></tr><tr><td rowspan="1" colspan="1">12.86</td><td rowspan="1" colspan="1">oxiranemethanol</td><td rowspan="1" colspan="1">1130</td><td rowspan="1" colspan="1">1065</td><td rowspan="1" colspan="1">0.29</td></tr><tr><td rowspan="1" colspan="1">13.605</td><td rowspan="1" colspan="1">neo-isopulegol</td><td rowspan="1" colspan="1">1148</td><td rowspan="1" colspan="1">1144</td><td rowspan="1" colspan="1">0.58</td></tr><tr><td rowspan="1" colspan="1">13.95</td><td rowspan="1" colspan="1">citronellal</td><td rowspan="1" colspan="1">1157</td><td rowspan="1" colspan="1">1148</td><td rowspan="1" colspan="1">27.34</td></tr><tr><td rowspan="1" colspan="1">14.075</td><td rowspan="1" colspan="1">not identified</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">0.31</td></tr><tr><td rowspan="1" colspan="1">14.37</td><td rowspan="1" colspan="1">phellandral</td><td rowspan="1" colspan="1">1076</td><td rowspan="1" colspan="1">1148</td><td rowspan="1" colspan="1">0.20</td></tr><tr><td rowspan="1" colspan="1">15.135</td><td rowspan="1" colspan="1">not identified</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">0.40</td></tr><tr><td rowspan="1" colspan="1">15.62</td><td rowspan="1" colspan="1"><italic>trans</italic>-4-Nonenal</td><td rowspan="1" colspan="1">1197</td><td rowspan="1" colspan="1">1148</td><td rowspan="1" colspan="1">0.05</td></tr><tr><td rowspan="1" colspan="1">16.095</td><td rowspan="1" colspan="1">decanal</td><td rowspan="1" colspan="1">1208</td><td rowspan="1" colspan="1">1201</td><td rowspan="1" colspan="1">0.52</td></tr><tr><td rowspan="1" colspan="1">17.135</td><td rowspan="1" colspan="1"><italic>&#x003b2;</italic>-citronellol</td><td rowspan="1" colspan="1">1232</td><td rowspan="1" colspan="1">1223</td><td rowspan="1" colspan="1">12.49</td></tr><tr><td rowspan="1" colspan="1">17.715</td><td rowspan="1" colspan="1">neral</td><td rowspan="1" colspan="1">1245</td><td rowspan="1" colspan="1">1235</td><td rowspan="1" colspan="1">10.31</td></tr><tr><td rowspan="1" colspan="1">18.335</td><td rowspan="1" colspan="1">geraniol</td><td rowspan="1" colspan="1">1260</td><td rowspan="1" colspan="1">1249</td><td rowspan="1" colspan="1">23.21</td></tr><tr><td rowspan="1" colspan="1">19.011</td><td rowspan="1" colspan="1">geranial</td><td rowspan="1" colspan="1">1276</td><td rowspan="1" colspan="1">1264</td><td rowspan="1" colspan="1">13.37</td></tr><tr><td rowspan="1" colspan="1">22.42</td><td rowspan="1" colspan="1">citronellol acetate</td><td rowspan="1" colspan="1">1356</td><td rowspan="1" colspan="1">1350</td><td rowspan="1" colspan="1">0.30</td></tr><tr><td rowspan="1" colspan="1">23.725</td><td rowspan="1" colspan="1">geranyl acetate</td><td rowspan="1" colspan="1">1387</td><td rowspan="1" colspan="1">1379</td><td rowspan="1" colspan="1">0.20</td></tr><tr><td rowspan="1" colspan="1">25.25</td><td rowspan="1" colspan="1"><italic>&#x003b2;</italic>-caryophyllene</td><td rowspan="1" colspan="1">1424</td><td rowspan="1" colspan="1">1417</td><td rowspan="1" colspan="1">1.07</td></tr><tr><td rowspan="1" colspan="1">26.64</td><td rowspan="1" colspan="1"><italic>&#x003b1;</italic>-humulene</td><td rowspan="1" colspan="1">1458</td><td rowspan="1" colspan="1">1452</td><td rowspan="1" colspan="1">0.09</td></tr><tr><td rowspan="1" colspan="1">29.09</td><td rowspan="1" colspan="1">germacrene-D</td><td rowspan="1" colspan="1">1519</td><td rowspan="1" colspan="1">1513</td><td rowspan="1" colspan="1">1.24</td></tr><tr><td rowspan="1" colspan="1">29.455</td><td rowspan="1" colspan="1"><italic>&#x003b4;</italic>-cadinene</td><td rowspan="1" colspan="1">1528</td><td rowspan="1" colspan="1">1522</td><td rowspan="1" colspan="1">0.22</td></tr><tr><td rowspan="1" colspan="1">29.57</td><td rowspan="1" colspan="1">citronellyl butyrate</td><td rowspan="1" colspan="1">1531</td><td rowspan="1" colspan="1">1530</td><td rowspan="1" colspan="1">0.21</td></tr><tr><td rowspan="1" colspan="1">30.47</td><td rowspan="1" colspan="1">elemol</td><td rowspan="1" colspan="1">1554</td><td rowspan="1" colspan="1">1563</td><td rowspan="1" colspan="1">0.17</td></tr><tr><td rowspan="1" colspan="1">30.845</td><td rowspan="1" colspan="1">geraniol butyrate</td><td rowspan="1" colspan="1">1564</td><td rowspan="1" colspan="1">1548</td><td rowspan="1" colspan="1">0.15</td></tr><tr><td rowspan="1" colspan="1">31.820</td><td rowspan="1" colspan="1">caryophyllene oxide</td><td rowspan="1" colspan="1">1589</td><td rowspan="1" colspan="1">1582</td><td rowspan="1" colspan="1">0.59</td></tr><tr><td rowspan="1" colspan="1">34.035</td><td rowspan="1" colspan="1"><italic>trans</italic>-cadinol</td><td rowspan="1" colspan="1">1648</td><td rowspan="1" colspan="1">1638</td><td rowspan="1" colspan="1">0.12</td></tr><tr><td rowspan="1" colspan="1">34.5</td><td rowspan="1" colspan="1"><italic>&#x003b1;</italic>-muurolol</td><td rowspan="1" colspan="1">1661</td><td rowspan="1" colspan="1">1644</td><td rowspan="1" colspan="1">0.29</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="6" colspan="2">Monoterpene hydrocarbons<break/>Oxygen containing monoterpenes<break/>Sesquiterpene hydrocarbons<break/>Oxygen containing sesquiterpenes<break/>Other compounds<break/>Total identified</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3.73</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">89.93</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3.33</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.91</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.56</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">98.46</td></tr></tbody></table><table-wrap-foot><fn id="tfn0002"><p><bold>Notes:</bold>
<sup>a</sup>Arithmetic retention indices<xref rid="cit0020" ref-type="bibr">20</xref> relative to C8-C20 <italic>n</italic>-alkanes calculated.<xref rid="cit0021" ref-type="bibr">21</xref>; <sup>b</sup>Arithmetic retention indices.<xref rid="cit0020" ref-type="bibr">20</xref>,<xref rid="cit0021" ref-type="bibr">21</xref></p></fn></table-wrap-foot></table-wrap>
</p><p>The citronellal concentration calculated from the analytical curve (area = 5,575,407, R<sup>2</sup> = 0.997) was 2.653 mg/mL, which corresponds to a citronellal concentration in the EO of 26.5% (w/w). The citronellol concentration (area = 2,196,889, R<sup>2</sup> = 0.996) was 1.116 mg/mL, which can be expressed as 11.1%. The geraniol concentration (area = 4,318,673, R<sup>2</sup> = 0.997) was 2.458 mg/mL, which corresponded to 24.6%. These values are consistent with the quantification from the chromatogram peak area normalization method by GC-MS.</p><p>EOs from the genus <italic>Cymbopogon</italic> have monoterpenes as their main chemical constituents. Variations in the chemical composition of EOs may occur due to several factors, such as climate, genetics, environment, seasonal variation, geographical conditions, and extraction methods.<xref rid="cit0033" ref-type="bibr">33&#x02013;36</xref></p><p>This EO chemical profile corroborated the results of a previous study that showed a citronellal concentration of 27.87% in the EO of <italic>C. nardus</italic> (Toledo et al, 2016), which is similar to the concentration found in this study (27.34%) and in a study by Wei and Wee (2013),<xref rid="cit0037" ref-type="bibr">37</xref> which reported a citronellal concentration of 29.6%. Studies performed by Kandimalla et al<xref rid="cit0038" ref-type="bibr">38</xref> (2016) in India and Nakahara et al<xref rid="cit0039" ref-type="bibr">39</xref> (2003) in Japan showed low concentrations of citronellal in the OE of <italic>C. nardus</italic> (6.06% and 5.8%, respectively). Kandimalla et al<xref rid="cit0038" ref-type="bibr">38</xref> (2016) found that the main constituents were citral (38.75%) and 2,6-octadienal,3,7-dimethyl (31.02%) and Nakahara et al<xref rid="cit0039" ref-type="bibr">39</xref> (2003) reported geraniol as the main chemical component, with a concentration of 35.7%.</p><p>Identification of the chemical compounds in the EO responsible for antimicrobial activity is difficult, since the essential oils are complex mixtures with different chemical compounds that can act synergistically.<xref rid="cit0040" ref-type="bibr">40</xref>,<xref rid="cit0041" ref-type="bibr">41</xref> A previous study has shown that the EO of <italic>C. nardus</italic> has greater antifungal activity against planktonic cells of <italic>Candida</italic> species than citronellal, which is its main chemical compound. This indicates a possible synergic action among the chemical compounds present in the EO.<xref rid="cit0010" ref-type="bibr">10</xref></p></sec><sec id="s0003-s2002"><title>Microemulsion Formation</title><p>A phase diagram (<xref ref-type="fig" rid="f0001">Figure 1</xref>) was constructed to demonstrate the 36 points of formulations obtained from the mixtures of different constituents and a visual classification was evaluated for each formulation. The formulations were visually classified as a transparent liquid system (TLS), an opaque liquid system (OLS), a semi-transparent liquid system (STLS), a phase separation (PS), a transparent viscous system (TVS), an opaque viscous system (OVS), or a semi-transparent viscous system (STVS). Therefore, different regions of the phase diagram were delineated and the best formulation for loading the essential oil in the ME was selected. The ME with the TLS characteristic (circled red point &#x02013; Point 9) was chosen for use in in vitro and in vivo assays. It was composed of 70% PBS, 20% Brij35 + soy phosphatidylcholine (2:1), and 10% grape seed oil. The EO (2000 &#x000b5;g/mL) was loaded in the ME (point 9, ME+EO).<fig id="f0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Phase diagram for formulations containing PBS (AP), Brij 35<sup>&#x000ae;</sup> + soy phosphatidylcholine and grape seed oil (OP).</p></caption><graphic content-type="print-only" xlink:href="IJN-15-10481-g0001"/><attrib><bold>Abbreviations:</bold> (S), grape seed oil (OP); AP, aqueous phase (PBS); S, surfactant (Brij 35<sup>&#x000ae;</sup>); OP, oil phase (grape seed oil); TLS, transparent liquid system; OLS, opaque liquid system; STLS, semi-transparent liquid system; PS, phase separation; TVS, transparent viscous system; OVS, opaque viscous system; STVS, semi-transparent viscous system.</attrib></fig></p></sec><sec id="s0003-s2003"><title>Microemulsion Characterization</title><sec id="s0003-s2003-s3001"><title>Mean Diameter, Polydispersity Index, and Zeta Potential</title><p>The mean values and standard deviation of particle size and PDI for the ME and ME+EO are demonstrated in <xref rid="t0003" ref-type="table">Table 3</xref>. According to Formariz et al<xref rid="cit0042" ref-type="bibr">42</xref> (2010) the particle size of MEs range from 10 to 250 nm. The results obtained in this study corroborate these data, since the particles sizes were 55.23 and 70.14 nm for the ME and ME+EO, respectively. Small differences in particle diameter size were observed between the ME and ME+EO, which suggested the incorporation of the EO in the ME. PDI is an index that evaluates the relative homogeneity of the particle sizes distributed in the sample.<xref rid="cit0043" ref-type="bibr">43</xref>,<xref rid="cit0044" ref-type="bibr">44</xref> Therefore, these results demonstrated that the ME and ME+EO were homogeneous. These data confirmed the results of a previous study of an ME containing orange oil, with varying oil concentrations of 20%, 25%, and 30%, which exhibited a particle size of 70 nm and an IPD of 0.22 nm.<xref rid="cit0045" ref-type="bibr">45</xref><table-wrap id="t0003" orientation="portrait" position="float"><label>Table 3</label><caption><p>Mean Diameter of the Particle Size, Polydispersity (PDI) and Zeta Potential for ME and ME+EO After 24 h (T0) and 3 Months (T3) of Samples Preparation</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Samples</th><th colspan="2" rowspan="1">Mean Diameter &#x000b1; SD (nm)*</th><th colspan="2" rowspan="1">Mean PDI &#x000b1; SD (nm)*</th><th colspan="2" rowspan="1">Zeta Potential &#x000b1; SD (mV)</th></tr><tr><th rowspan="1" colspan="1">T0</th><th rowspan="1" colspan="1">T3</th><th rowspan="1" colspan="1">T0</th><th rowspan="1" colspan="1">T3</th><th rowspan="1" colspan="1">T0</th><th rowspan="1" colspan="1">T3</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">ME</td><td rowspan="1" colspan="1">55.2&#x000b1;0.291</td><td rowspan="1" colspan="1">57.3&#x000b1;0.191</td><td rowspan="1" colspan="1">0.35&#x000b1;0.04</td><td rowspan="1" colspan="1">0.32&#x000b1;0.020</td><td rowspan="1" colspan="1">&#x02212; 2.8&#x000b1;,0.929</td><td rowspan="1" colspan="1">&#x02212;2.9&#x000b1;0.072</td></tr><tr><td rowspan="1" colspan="1">ME+EO</td><td rowspan="1" colspan="1">70.1&#x000b1;0.848</td><td rowspan="1" colspan="1">72.2&#x000b1;0.032</td><td rowspan="1" colspan="1">0.39&#x000b1;0.006</td><td rowspan="1" colspan="1">0.35&#x000b1;0.053</td><td rowspan="1" colspan="1">&#x02212; 2.8&#x000b1;0.349</td><td rowspan="1" colspan="1">&#x02212;2.9&#x000b1;0.092</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><bold>Notes:</bold> *Values expressed in nanometer (mean diameter and PDI) and millivolts (ZP) by determining of mean and standard deviation from three different assays.</p><p><bold>Abbreviations:</bold> ME, microemulsion; ME+EO, loaded essential oil in the microemulsion.</p></fn></table-wrap-foot></table-wrap>
</p><p>An analysis of the ZP of the ME and ME+EO showed a negative charge, which is likely due to the presence of soy phosphatidylcholine in the system that may favor the negative potential because of free esters present in the lipid structure.<xref rid="cit0046" ref-type="bibr">46</xref> However, phosphatidylcholine provides a phosphate group (negative charge) and a choline group (positive charge), which can cancel out each other, generating a zero charge at neutral pH. Thus, the hydration layers, lipid headgroups, and water polarization are factors that can be considered as the cause of the negative ZP.<xref rid="cit0047" ref-type="bibr">47</xref>,<xref rid="cit0048" ref-type="bibr">48</xref> No significant changes were observed between time 0 and time 3 months, in relation to the particle diameter, IPD and zeta potential, which indicates stability of ME and ME+EO.</p></sec><sec id="s0003-s2003-s3002"><title>PLM</title><p>The ME and ME+EO were analyzed by PLM to evaluate the structure of the formulations. <xref ref-type="fig" rid="f0002">Figure 2</xref> shows the PLM photomicrographs of the ME (A) and ME+EO (B). Photomicrography A (10% oil phase) showed isotropic behavior (dark field), which, in the plane of polarized light, did not deviate light, suggesting the formation of a microemulsified system. Photomicrography B (10% oil phase), after the incorporation of the EO in the ME, also showed a dark field and therefore, the lipid system containing the active ingredient maintains the characteristics of a microemulsified system.<fig id="f0002" fig-type="figure" orientation="portrait" position="float"><label>Figure 2</label><caption><p>PLM photomicrographs of ME (<bold>A</bold>) and ME+EO (<bold>B</bold>) at magnification 20&#x000d7;.</p></caption><graphic content-type="print-only" xlink:href="IJN-15-10481-g0002"/></fig></p></sec><sec id="s0003-s2003-s3003"><title>Oscillatory Rheology</title><p>The viscoelastic behavior of the formulations (ME and ME+EO) was evaluated by oscillatory measurements. Rheological analyses are relevant, as they provide parameters for the characterization of the formulations, including structure and viscosity, which are important for the development of formulations for topical use.<xref rid="cit0049" ref-type="bibr">49</xref> G&#x02032; represents the storage modulus of the energy of stress, which can be restored when the stress is released and G&#x02033; represents the flow resistance of the sample.<xref rid="cit0050" ref-type="bibr">50</xref></p><p><xref ref-type="fig" rid="f0003">Figure 3</xref> shows the elastic modulus (G&#x02032;) and viscous modulus (G&#x02033;) of the formulations. The ME and ME+EO showed elastic behavior (G&#x02032; &#x0003e; G&#x02033;), indicating a highly organized structure. These results demonstrated that the incorporation of EO in the system did not alter the viscoelastic behavior of the formulations. Viscoelasticity is important for vaginal application, due to the ease of administration and suitable scattering in the vaginal environment.<xref rid="cit0051" ref-type="bibr">51</xref><fig id="f0003" fig-type="figure" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Rheological behavior in oscillatory flow conditions of ME and ME+EO.</p></caption><graphic content-type="print-only" xlink:href="IJN-15-10481-g0003"/></fig></p></sec><sec id="s0003-s2003-s3004"><title>Continuous Shear Rheology</title><p>Continuous shear rheology data for the ME and ME+EO are shown in <xref ref-type="fig" rid="f0004">Figure 4</xref>. The ascending (filled symbol) and descending curves (empty symbol) indicate the flow behavior of the formulations. <xref rid="t0004" ref-type="table">Table 4</xref> shows the properties related to flow behavior (<italic>n</italic>) and consistency of the formulations (<italic>k</italic>). The ME and ME+EO demonstrated non-Newtonian characteristics, with pseudoplastic behavior (<italic>n</italic> &#x0003c; 1). This result is relevant for the appropriate application of pseudoplastic formulations in the vaginal environment, since an increase in viscosity occurs under the application of shear stress; however, when the force is removed, the system structure returns to its initial properties.<xref rid="cit0052" ref-type="bibr">52</xref><table-wrap id="t0004" orientation="portrait" position="float"><label>Table 4</label><caption><p>Flow Behavior (n) and Consistency Index (<italic>k</italic>) of ME and ME+EO by Continuous Flow Rheology</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Formulations</th><th rowspan="1" colspan="1">n</th><th rowspan="1" colspan="1"><italic>K</italic></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">ME</td><td rowspan="1" colspan="1">0.7543&#x000b1;0.04</td><td rowspan="1" colspan="1">0.3218&#x000b1;0.06</td></tr><tr><td rowspan="1" colspan="1">ME+EO</td><td rowspan="1" colspan="1">0.7846&#x000b1;0.06</td><td rowspan="1" colspan="1">0.3688&#x000b1;0.10</td></tr></tbody></table><table-wrap-foot><fn id="tfn0004"><p><bold>Abbreviations:</bold> ME, free formulation; ME+EO, loaded essential oil in the ME.</p></fn></table-wrap-foot></table-wrap>
<fig id="f0004" fig-type="figure" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Continuous shear rheogram of ME and ME+EO. Filled symbol represents the ascending curve and empty symbol indicates the descending curve; up arrow: ascending; down arrow: descending.</p></caption><graphic content-type="print-only" xlink:href="IJN-15-10481-g0004"/></fig></p><p>These results are in agreement with the work of Ramos et al<xref rid="cit0024">24</xref> (2019), who showed that a methanolic extract of <italic>Syngonanthus nitens</italic> loaded in a nanoemulsion showed pseudoplastic behavior and allowed effective application for vulvovaginal candidiasis treatment. Another study demonstrated the pseudoplastic behavior of multiple emulsions loaded with clotrimazole as an adequate topical (vaginal) delivery system, showing effective antifungal activity when compared to clotrimazole, a commercial antimycotic drug.<xref rid="cit0053" ref-type="bibr">53</xref></p></sec><sec id="s0003-s2003-s3005"><title>Mucoadhesion Properties</title><p>Suitable mucoadhesion characteristics are relevant for the attachment of a formulation to vaginal mucosal membranes, in order to promote extended contact between the formulation and the vaginal cavity, thus allowing an increased residence time and bioavailability of the drug. Moreover, adequate mucoadhesion avoids drainage of the formulation outside the vagina, which is an unfortunate condition for users.<xref rid="cit0054" ref-type="bibr">54</xref></p><p>The peaks of mucoadhesion of the ME and ME+EO are shown in <xref ref-type="fig" rid="f0005">Figure 5</xref>. There was no significant difference (<italic>p</italic> &#x0003e; 0.05) in mucoadhesion between the ME and ME+EO, indicating that, after incorporation of the EO in the ME, mucoadhesion remained stable. The formulations showed adequate mucoadhesion for use in an in vivo VVC assay, which was in agreement with the results of studies by Bonif&#x000e1;cio et al<xref rid="cit0022">22</xref> (2015) and Ramos et al<xref rid="cit0024">24</xref> (2019), in which the mucoadhesivity of loaded vegetal extracts in nanoemulsioned formulations were suitable for application in in vivo vulvovaginal candidiasis studies.<fig id="f0005" fig-type="figure" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Peak of mucoadhesion (N.s) of ME and ME+EO. Each value represents the mean (&#x000b1; standard deviation) of at least five replicates.</p></caption><graphic content-type="print-only" xlink:href="IJN-15-10481-g0005"/></fig></p></sec><sec id="s0003-s2003-s3006"><title>Transmission Electron Microscopy</title><p><xref ref-type="fig" rid="f0006">Figure 6</xref> shows TEM images of the ME and ME+EO at a magnification of 50,000&#x000d7;. The photomicrographs of the ME and ME+EO showed spherical structures; however, ME+EO images showed possible EO droplets inside the spherical structures, which suggested incorporation of the EO.<xref rid="cit0055" ref-type="bibr">55</xref> The particle sizes of the formulations obtained from DLS measurements were confirmed by TEM photomicrographs, which showed particles ranging from 50 to 200 nm.<fig id="f0006" fig-type="figure" orientation="portrait" position="float"><label>Figure 6</label><caption><p>TEM photomicrographs of the ME (<bold>A</bold>) and ME+EO (<bold>B</bold>) at magnification of 50,000&#x000d7;.</p></caption><graphic content-type="print-only" xlink:href="IJN-15-10481-g0006"/></fig></p></sec></sec><sec id="s0003-s2004"><title>Antifungal Activity</title><sec id="s0003-s2004-s3001"><title>MIC and MFC of EO and ME+EO</title><p>The MIC and MFC results for EO and ME+EO are shown in <xref rid="t0005" ref-type="table">Table 5</xref>. The EO showed antifungal activity with MIC values of 500 &#x000b5;g/mL and &#x0003e;500 &#x000b5;g/mL against <italic>C. albicans</italic> ATCC and CAV, respectively. ME+EO showed the lowest MIC (31.2 &#x000b5;g/mL) against CAATCC and CAV (62.5 &#x000b5;g/mL). Thus, the use of an ME considerably improved the action of the EO. The growth control showed satisfactory results, whereas the solvent and ME controls did not show any antifungal activity.<table-wrap id="t0005" orientation="portrait" position="float"><label>Table 5</label><caption><p>MIC and MFC of EO and ME+EO Against <italic>C. albicans</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"><italic>C. albicans</italic></th><th colspan="4" rowspan="1">MIC/MFC* MIC*</th></tr><tr><th rowspan="1" colspan="1">EO</th><th rowspan="1" colspan="1">ME+EO</th><th rowspan="1" colspan="1">AMB</th><th rowspan="1" colspan="1">FLU</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">CA-ATCC 10231</td><td rowspan="1" colspan="1">500/500</td><td rowspan="1" colspan="1">31.2/&#x0003e;500</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">R</td></tr><tr><td rowspan="1" colspan="1">CAV</td><td rowspan="1" colspan="1">&#x0003e;500/&#x0003e;500</td><td rowspan="1" colspan="1">62.5/&#x0003e;500</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">R</td></tr></tbody></table><table-wrap-foot><fn id="tfn0005"><p><bold>Note:</bold> *Values expressed in &#x000b5;g/mL.</p><p><bold>Abbreviations:</bold> EO, essential oil; ME+EO, loaded essential oil in the microemulsion; AMB, amphotericin-B; FLU, fluconazole; CA-ATCC 10231, standard strain of <italic>C. albicans</italic>; CVV, clinical strain of <italic>C. albicans.</italic></p></fn></table-wrap-foot></table-wrap>
</p><p>Several studies have demonstrated the anti-<italic>Candida</italic> activity of EOs.<xref rid="cit0056" ref-type="bibr">56&#x02013;59</xref> The genus <italic>Cymbopogon</italic> has been shown to have effective antifungal activity against pathogenic fungi. A previous study demonstrated the antifungal activity of the EO of <italic>Cymbopogon citratus</italic> against different <italic>Candida</italic> species, showing MIC values ranging from 125 to 175 &#x000b5;g/mL.<xref rid="cit0060" ref-type="bibr">60</xref> Another study demonstrated the anti-<italic>Candida</italic> action of the EO from <italic>C. nardus</italic> against <italic>C. albicans</italic>, with MIC values ranging from 32 to 64 &#x000b5;g/mL. Furthermore, the EO of <italic>C. nardus</italic> inhibits the adherence of <italic>C. albicans</italic> to dental implants and cover screws.<xref rid="cit0061" ref-type="bibr">61</xref></p><p>The use of nanotechnology as an alternative to improving the antifungal activity of natural products has been used with promising results. In an in vivo study of the prophylactic action of a methanolic extract of <italic>Syngonanthus nitens</italic> (Bong.) Rhulland loaded into a drug delivery system, the prevention of VVC development caused by <italic>C. krusei</italic> was demonstrated.<xref rid="cit0062" ref-type="bibr">62</xref> Bonif&#x000e1;cio et al<xref rid="cit0022">22</xref> (2015) studied the antifungal activity of an ethanolic extract from <italic>Astronium urundeuva</italic> (Engl.), unloaded or loaded in an ME, against <italic>C. albicans</italic> and showed an improvement in the inhibitory capacity of the extract after incorporation into the nanostructured system.</p><p>The incorporation of oils<xref rid="cit0063" ref-type="bibr">63</xref> and chemical compounds from EOs<xref rid="cit0064" ref-type="bibr">64</xref> in nanostructured delivery systems has been used to combat microorganisms. A previous study showed greater antifungal activity against <italic>Candida</italic> species using clotrimazole loaded into lipid nanoparticles containing EOs compared to prolonged in vitro delivery of clotrimazole. Moreover, increased anti-<italic>Candida</italic> action was observed for loaded clotrimazole nanoparticles prepared with EOs of <italic>Lavandula</italic> or <italic>Rosmarinus</italic>.<xref rid="cit0065" ref-type="bibr">65</xref></p><p>The use of MEs is important to enhance the solubilization of the EO, which improves the safety and stability of the system and consequently, may enhance the antifungal activity of the EO.<xref rid="cit0066" ref-type="bibr">66</xref></p></sec><sec id="s0003-s2004-s3002"><title>Ergosterol and Sorbitol</title><p><xref rid="t0006" ref-type="table">Table 6</xref> shows MIC values for EO, ME+EO, and AmB, in the absence and presence of exogenous ergosterol, against <italic>C. albicans</italic> ATCC 10231 and CAV. The MIC values of EO and ME+EO increased 5-fold and 20-fold, respectively, in the presence of exogenous ergosterol. These results suggested that EO and ME+EO bound to ergosterol in the fungal membrane, which required higher concentrations of EO and ME+EO to promote fungal cell death, demonstrating action on the ionic permeability of the fungal cell membrane. The positive control (AmB) showed the same mode of action. The antifungal activities of EO and ME+EO are not related to the biosynthetic pathways of the cell wall, since the MIC values were maintained in the presence of sorbitol.<table-wrap id="t0006" orientation="portrait" position="float"><label>Table 6</label><caption><p>MIC Values of EO, ME+EO and Amphotericin-B (AMB) in Absence (A) and Presence (P) of Exogenous Ergosterol Against <italic>C. albicans</italic> ATCC 10231 and CAV</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" colspan="1"><italic>C. albicans</italic></th><th colspan="6" rowspan="1">MIC (&#x003bc;g/mL)</th></tr><tr><th colspan="2" rowspan="1">EO</th><th colspan="2" rowspan="1">ME+EO</th><th colspan="2" rowspan="1">AMB</th></tr><tr><th rowspan="1" colspan="1">(A)</th><th rowspan="1" colspan="1">(P)</th><th rowspan="1" colspan="1">(A)</th><th rowspan="1" colspan="1">(P)</th><th rowspan="1" colspan="1">(A)</th><th rowspan="1" colspan="1">(P)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">CA-ATCC 10231</td><td rowspan="1" colspan="1">500</td><td rowspan="1" colspan="1">2500</td><td rowspan="1" colspan="1">31.2</td><td rowspan="1" colspan="1">625</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">CVV</td><td rowspan="1" colspan="1">&#x0003e;500</td><td rowspan="1" colspan="1">5000</td><td rowspan="1" colspan="1">62.5</td><td rowspan="1" colspan="1">&#x0003e;5000</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">4</td></tr></tbody></table><table-wrap-foot><fn id="tfn0006"><p><bold>Abbreviations:</bold> EO, essential oil; ME+EO, loaded essential oil in the microemulsion; AMB, amphotericin-B; A, absence; P, presence; CA-ATCC 10231, standard strain of <italic>C. albicans</italic>; CVV, clinical strain of <italic>C. albicans.</italic></p></fn></table-wrap-foot></table-wrap>
</p><p>A previous study investigated the mode of action of <italic>Thyme vulgaris</italic> EO, against <italic>Rhizopus oryzae</italic>, via interaction with ergosterol, and verified that this EO can interact with the fungal membrane, as evidenced by increasing MIC values in the presence of ergosterol.<xref rid="cit0067" ref-type="bibr">67</xref> Another study demonstrated that <italic>Laurus nobilis</italic> EO may interfere have two mechanisms of action against <italic>C. albicans</italic>, (cell wall biosynthesis and ionic permeability of the fungal cell membrane), considering that increased MIC values for this EO are observed in the presence of ergosterol and sorbitol.<xref rid="cit0028" ref-type="bibr">28</xref></p></sec></sec><sec id="s0003-s2005"><title>Toxicity Studies</title><sec id="s0003-s2005-s3001"><title>HaCat Cell Line</title><p><xref rid="t0007" ref-type="table">Table 7</xref> shows the cytotoxic activity (IC<sub>50</sub>) of the EO, ME+EO, and ME against HaCat cells. The EO showed lower cytotoxicity than ME+EO and ME. Koba et al<xref rid="cit0068">68</xref>(2009) compared the cytotoxicity of EOs from the genus <italic>Cymbopogon</italic> (<italic>C. nardus</italic> and <italic>C. citratus</italic>) against HaCat cells and showed that the <italic>C. nardus</italic> EO had lower cytotoxicity than the <italic>C. citratus</italic> EO, with IC<sub>50</sub> values of 450 &#x000b5;L/mL and 150 &#x000b5;L/mL, respectively.<table-wrap id="t0007" orientation="portrait" position="float"><label>Table 7</label><caption><p>Cytotoxic Activity (IC<sub>50</sub>) of EO, ME+EO and ME Against HaCat Cell Line</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Samples</th><th rowspan="1" colspan="1">HaCat (IC<sub>50</sub>)*</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">EO</td><td rowspan="1" colspan="1">235</td></tr><tr><td rowspan="1" colspan="1">ME+EO</td><td rowspan="1" colspan="1">5.5</td></tr><tr><td rowspan="1" colspan="1">ME</td><td rowspan="1" colspan="1">4.5</td></tr></tbody></table><table-wrap-foot><fn id="tfn0007"><p><bold>Note:</bold> *Values expressed in &#x003bc;g/mL.</p><p><bold>Abbreviations:</bold> EO, essential oil; ME+EO, loaded essential oil in the microemulsion; ME, microemulsion.</p></fn></table-wrap-foot></table-wrap>
</p><p>The IC<sub>50</sub> values of the ME+EO and ME were similar to conventional drugs used in the clinical practice, such as AmB (IC<sub>50</sub> = 4.0 &#x003bc;g/mL).<xref rid="cit0024" ref-type="bibr">24</xref> Topical administration is proposed for the formulations in this study. The route of administration is important for toxicity parameters, since topical administration exhibits lower toxicity than oral administration.<xref rid="cit0069" ref-type="bibr">69</xref></p></sec><sec id="s0003-s2005-s3002"><title>Brine Shrimp Lethality</title><p><xref rid="t0008" ref-type="table">Table 8</xref> shows the lethal concentration (LD<sub>50</sub>) of the EO, ME+EO, and ME against brine shrimp (<italic>A. salina)</italic> nauplii. Several studies have described the toxicity of EOs against brine shrimp nauplii.<xref rid="cit0070" ref-type="bibr">70&#x02013;72</xref> However, the results of this study showed that EO was not toxic against brine shrimp nauplii, with LD<sub>50</sub> values higher than 1000 &#x003bc;g/mL. Moreover, brine shrimp nauplii treated with ME+EO and ME were found to be viable, with LD<sub>50</sub> values &#x0003e;30 &#x003bc;g/mL, which was the highest tested concentration of these formulations in this assay.<table-wrap id="t0008" orientation="portrait" position="float"><label>Table 8</label><caption><p>Lethal Concentration (LD<sub>50</sub>) of EO, ME+EO and ME Against Brine Shrimp Nauplii</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Samples</th><th rowspan="1" colspan="1"><italic>Artemia salina</italic>&#x000a0;(LD<sub>50</sub>)*</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">EO</td><td rowspan="1" colspan="1">&#x0003e;1000</td></tr><tr><td rowspan="1" colspan="1">ME+EO</td><td rowspan="1" colspan="1">&#x0003e;30</td></tr><tr><td rowspan="1" colspan="1">ME</td><td rowspan="1" colspan="1">&#x0003e;30</td></tr></tbody></table><table-wrap-foot><fn id="tfn0008"><p><bold>Note:</bold> *Values expressed in &#x003bc;g/mL.</p><p><bold>Abbreviations:</bold> EO, essential oil; ME+EO, loaded essential oil in the microemulsion; ME, microemulsion.</p></fn></table-wrap-foot></table-wrap>
</p><p>Parra et al<xref rid="cit0030">30</xref> (2001) used the <italic>A. salina</italic> model to determine the toxicity of 20 plant extracts. The authors found a good correlation between in vivo and in vitro tests, concluding that brine shrimp lethality studies are a useful alternative to predict the acute oral toxicity of plant extracts. Moreover, the <italic>A. salina</italic> model is a useful tool for toxicity studies, due to the benefits of the method, which include quickness, cost-effectiveness, and reproducibility.<xref rid="cit0073" ref-type="bibr">73</xref></p></sec><sec id="s0003-s2005-s3003"><title>In vivo VVC Assay</title><p><xref rid="t0009" ref-type="table">Table 9</xref> shows the results of fungal burden (CFU) from vaginal lavages collected at days 2, 4, 6, and 8. The EO of <italic>C. nardus</italic> was found to have significant therapeutic activity against VVC caused by <italic>C. albicans</italic> in mice. All animals treated with ME+EO were cured on the third day of treatment (experimental day 5). Moreover, incorporation of the EO into an ME enhanced the antifungal action of the EO (free), which was able to eradicate fungal infection in 50% of the animals. In the positive infection, solvent, and ME control experimental groups, the infection remained constant on all days of treatment, with a high fungal load present in 100% of the animals.<table-wrap id="t0009" orientation="portrait" position="float"><label>Table 9</label><caption><p>Fungal Burden (CFU) from the Vaginal Lavages Collected at Days 2, 4, 6 and 8, During Treatment Period</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Experimental<break/>Groups</th><th rowspan="1" colspan="1"/><th colspan="7" rowspan="1">Days/CFU/mL*</th></tr><tr><th rowspan="1" colspan="1">IA</th><th rowspan="1" colspan="1">2</th><th rowspan="1" colspan="1">IA</th><th rowspan="1" colspan="1">4</th><th rowspan="1" colspan="1">IA</th><th rowspan="1" colspan="1">6</th><th rowspan="1" colspan="1">IAA</th><th rowspan="1" colspan="1">8</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Negative infection</td><td rowspan="1" colspan="1">0/8</td><td rowspan="1" colspan="1">0&#x000b1;0.00</td><td rowspan="1" colspan="1">0/8</td><td rowspan="1" colspan="1">0&#x000b1;0.00</td><td rowspan="1" colspan="1">0/8</td><td rowspan="1" colspan="1">0&#x000b1;0.00</td><td rowspan="1" colspan="1">0/8</td><td rowspan="1" colspan="1">0&#x000b1;0.00</td></tr><tr><td rowspan="1" colspan="1">Positive Infection</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">3&#x000b1;0.03</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">3.2&#x000b1;0.00</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">4.4&#x000b1;0.00**</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">4.5&#x000b1;0.00**</td></tr><tr><td rowspan="1" colspan="1">Positive control</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">2.6&#x000b1;0.05</td><td rowspan="1" colspan="1">5/8</td><td rowspan="1" colspan="1">3&#x000b1;0.01</td><td rowspan="1" colspan="1">5/8</td><td rowspan="1" colspan="1">3.6&#x000b1;0.00<sup>#</sup></td><td rowspan="1" colspan="1">5/8</td><td rowspan="1" colspan="1">3.8&#x000b1;0.00<sup>#</sup></td></tr><tr><td rowspan="1" colspan="1">Solvent control</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">2.6&#x000b1;0.05</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">3&#x000b1;0.01</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">4.4&#x000b1;0.00</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">4.5&#x000b1;0.01</td></tr><tr><td rowspan="1" colspan="1">EO</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">2.5&#x000b1;0.09</td><td rowspan="1" colspan="1">4/8</td><td rowspan="1" colspan="1">3&#x000b1;0.00</td><td rowspan="1" colspan="1">4/8</td><td rowspan="1" colspan="1">3.5&#x000b1;0.00 <sup>#</sup></td><td rowspan="1" colspan="1">4/8</td><td rowspan="1" colspan="1">3.7&#x000b1;0.00<sup>#</sup></td></tr><tr><td rowspan="1" colspan="1">ME+EO</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">2.4&#x000b1;0.04</td><td rowspan="1" colspan="1">3/8</td><td rowspan="1" colspan="1">2.4&#x000b1;0.3</td><td rowspan="1" colspan="1">0/8</td><td rowspan="1" colspan="1">0&#x000b1;0.00 <sup>a#**</sup></td><td rowspan="1" colspan="1">0/8</td><td rowspan="1" colspan="1">0&#x000b1;0.00 <sup>a#**</sup></td></tr><tr><td rowspan="1" colspan="1">ME control</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">2.9&#x000b1;0.02</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">3.1&#x000b1;0.01</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">4.2&#x000b1;0.00</td><td rowspan="1" colspan="1">8/8</td><td rowspan="1" colspan="1">4.3&#x000b1;0.00</td></tr></tbody></table><table-wrap-foot><fn id="tfn0009"><p><bold>Notes:</bold> *Values expressed as mean &#x000b1; standard deviation of CFU/mL (log) obtained from vaginal lavage cultures. <sup>a</sup>Statistically significant difference between the treatments on the days 6 and 8; <sup>#</sup>significant difference (p&#x0003c; 0.05); **very significant difference (p&#x0003c; 0.01).</p><p><bold>Abbreviations:</bold> EO, essential oil; ME+EO, loaded essential oil in the microemulsion; ME, microemulsion; IA, number of infected animals.</p></fn></table-wrap-foot></table-wrap>
</p><p>These data are significant, since the ME+EO demonstrated superior antifungal action compared with both free EO and a commercial cream used in clinical therapy (AmB + tetracycline), thus demonstrating the effectiveness of the nanotechnology application as an alternative to improve the antifungal activity of natural products.</p><p>Studies using in vivo experimental models of mucosal infections caused by <italic>Candida</italic> are typically performed with mammals (rats, mice) because of economic, ethical, and anatomical reasons, and because these animals are immunologically similar to humans.<xref rid="cit0074" ref-type="bibr">74&#x02013;76</xref></p><p>Previous studies have shown that plant extracts incorporated into nanostructured lipid systems are effective in the treatment rat models of VVC caused by <italic>C. albicans</italic>. Plant extracts loaded into nanostructured drug delivery systems were shown to be significantly more effective than unloaded plant extracts or the clinical practice drug, AmB, at the complete eradication of the vaginal fungal infection.<xref rid="cit0014" ref-type="bibr">14</xref>,<xref rid="cit0022" ref-type="bibr">22</xref></p><p>Rodero et al<xref rid="cit0015">15</xref> (2018) described the use of liquid crystalline systems to improve the action of curcumin in a mouse model of VVC. The authors showed effective antifungal activity of curcumin, loaded in the liquid crystalline system, against <italic>C. albicans</italic>. In addition, the loaded curcumin was effective at modulating the inflammatory response to the infection.</p><p>Pietrella et al<xref rid="cit0077" ref-type="bibr">77</xref> (2011) evaluated <italic>Mentha suaveolens</italic> EO in a mouse model of VVC (<italic>C. albicans</italic>). The authors reported that the EO was able to decrease the fungal load of the vaginal infection compared to the saline control, thus accelerating the removal of the infection.</p><p>Another study investigated the antifungal activity of clove EO in an emulsion and in a liposomal form in mice with VVC. After 8 d of treatment, a reduction in vaginal fungal load was observed for both forms tested. However, the liposomal form was found to be more effective than the emulsion form of the EO. In addition, the free EO was only able to eliminate the infection after 14 d.</p><p>These data corroborate the results of the present study, in which EOs were shown to have improved action when incorporated into a drug delivery system. In addition to improved antimicrobial activity, these drug delivery systems increase the stability and bioavailability of the plant extracts.<xref rid="cit0012" ref-type="bibr">12</xref></p></sec></sec></sec><sec id="s0004"><title>Conclusion</title><p>The main compounds of the EO of <italic>C. nardus</italic> were found to be the oxygen-containing monoterpenes, citronellal, geranial, geraniol, citronellol, and neral. The ME+EO showed adequate technological properties, providing stability of the system and improvement of solubilization of the EO for incorporation in the ME. The EO and ME+EO exhibited effective in vitro and in vivo antifungal activity against <italic>C. albicans</italic> and demonstrated possible actions on the ionic permeability of the fungal cell membrane. Moreover, the use of nanotechnology significantly improved the antifungal action of the EO, especially in an in vivo model of VVC, in which the ME+EO promoted the eradication of the fungal vaginal infection on the third day of treatment. These encouraging results suggest that the incorporation of the essential oil of <italic>C. nardus</italic> in an ME can considerably enhance the antifungal action of the EO against <italic>C. albicans</italic>. Additionally, EO extraction complies with the principles of green chemistry, being a viable process that facilitates the development and industrial-scale production of antifungal herbal medicines, based on citronella EO.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank S&#x000e3;o Paulo Research Foundation-FAPESP (grant #2015/23959-7, grant #2017-21356-9, grant #2016/08559-5, grant #2014/50926-0 and grant #2020/13057-4). This study was financed in part by the Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de Ensino Superior-Brasil (CAPES) &#x02013; Finance code-001.</p></ack><sec id="s0005"><title>Abbreviations</title><p>AmB, amphotericin-B; AP, aqueous phase; GC/MS, gas chromatography-mass spectrometry; DMEM, Dulbecco&#x02019;s Modified Eagle&#x02019;s Medium; DMSO, dimethylsulfoxide; EO, essential oil; FLU, fluconazole; ME, microemulsion; ME+EO, loaded essential oil in the microemulsion; OP, oil phase; PBS, phosphate-buffered saline; RPMI, Roswell Park Memorial Institute; S, surfactant SDA, Sabouraud Dextrose Agar; SDB, Sabouraud Dextrose broth; SisGen, National System for the Management of Genetic Heritage and Associated Traditional Knowledge; VVC, vulvovaginal candidiasis.</p></sec><sec id="s0006" sec-type="COI-statement"><title>Disclosure</title><p>The authors report no conflicts of interest in this work.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Lopez</surname>
<given-names>JEM</given-names></string-name>. <article-title>Candidiasis (vulvovaginal)</article-title>. <source><italic toggle="yes">Clin Evid (Online)</italic></source>. <year>2015</year>;<volume>3</volume>:<fpage>1</fpage>&#x02013;<lpage>23</lpage>.</mixed-citation></ref><ref id="cit0002"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Denning</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Kneale</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sobel</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Rautemaa-Richardson</surname>
<given-names>R</given-names></string-name>. <article-title>Global burden of recurrent vulvovaginal candidiasis: a systematic review</article-title>. <source><italic toggle="yes">Lancet Infect Dis</italic></source>. <year>2018</year>;<volume>18</volume>(<issue>11</issue>):<fpage>e339</fpage>&#x02013;<lpage>e347</lpage>. (). doi:<pub-id pub-id-type="doi">10.1016/S1473-3099(18)30103-8</pub-id><pub-id pub-id-type="pmid">30078662</pub-id></mixed-citation></ref><ref id="cit0003"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Cassone</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sobel</surname>
<given-names>JD</given-names></string-name>. <article-title>Experimental models of vaginal candidiasis and their relevance to human candidiasis</article-title>. <source><italic toggle="yes">Infect Immun</italic></source>. <year>2016</year>;<volume>84</volume>(<issue>5</issue>):<fpage>1255</fpage>&#x02013;<lpage>1261</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.01544-15</pub-id><pub-id pub-id-type="pmid">26883592</pub-id></mixed-citation></ref><ref id="cit0004"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Blostein</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Mph</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Wagner</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Foxman</surname>
<given-names>B</given-names></string-name>. <article-title>Annals of epidemiology recurrent vulvovaginal candidiasis</article-title>. <source><italic toggle="yes">Ann Epidemiol</italic></source>. <year>2017</year>;<volume>27</volume>(<issue>9</issue>):<fpage>575</fpage>&#x02013;<lpage>582.e3</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.annepidem.2017.08.010</pub-id><pub-id pub-id-type="pmid">28927765</pub-id></mixed-citation></ref><ref id="cit0005"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Ferreira</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Grenouillet</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Blasco</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization</article-title>. <source><italic toggle="yes">Intensive Care Med</italic></source>. <year>2015</year>;<volume>41</volume>(<issue>6</issue>):<fpage>1077</fpage>&#x02013;<lpage>1088</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00134-015-3791-4</pub-id><pub-id pub-id-type="pmid">25894623</pub-id></mixed-citation></ref><ref id="cit0006"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Perfect</surname>
<given-names>JR</given-names></string-name>. <article-title>Expert opinion on emerging drugs &#x0201c; Is there an emerging need for new antifungals ?&#x0201d;</article-title>. <source><italic toggle="yes">Expert Opin Emerg Drugs</italic></source>. <year>2016</year>;<volume>21</volume>(<issue>2</issue>):<fpage>129</fpage>&#x02013;<lpage>131</lpage>. doi:<pub-id pub-id-type="doi">10.1517/14728214.2016.1155554</pub-id><pub-id pub-id-type="pmid">26883732</pub-id></mixed-citation></ref><ref id="cit0007"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Zore</surname>
<given-names>GB</given-names></string-name>, <string-name><surname>Thakre</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>Rathod</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Karuppayil</surname>
<given-names>SM</given-names></string-name>. <article-title>Evaluation of anti-Candida potential of geranium oil constituents against clinical isolates of Candida albicans differentially sensitive to fluconazole: inhibition of growth, dimorphism and sensitization</article-title>. <source><italic toggle="yes">Mycoses</italic></source>. <year>2011</year>;<volume>54</volume>(<issue>4</issue>):<fpage>99</fpage>&#x02013;<lpage>109</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1439-0507.2009.01852.x</pub-id><pub-id pub-id-type="pmid">19732347</pub-id></mixed-citation></ref><ref id="cit0008"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Aini</surname>
<given-names>MNN</given-names></string-name>, <string-name><surname>Said</surname>
<given-names>MI</given-names></string-name>, <string-name><surname>Nazlina</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Hanina</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Ahmad</surname>
<given-names>IB</given-names></string-name>. <article-title>Screening for antiviral activity of sweet lemon grass (Cymbopogon nardus (L.) Rendle) fractions</article-title>. <source><italic toggle="yes">J Biol Sci</italic></source>. <year>2006</year>;<volume>6</volume>(<issue>3</issue>):<fpage>507</fpage>&#x02013;<lpage>510</lpage>. doi:<pub-id pub-id-type="doi">10.3923/jbs.2006.507.510</pub-id></mixed-citation></ref><ref id="cit0009"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Feyaerts</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>Math&#x000e9;</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Luyten</surname>
<given-names>W</given-names></string-name>, <string-name><surname>De Graeve</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Van Dyck</surname>
<given-names>K</given-names></string-name>. <article-title>Essential oils and their components are a class of antifungals with potent vapour-phase-mediated anti -Candida activity</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2018</year>;<volume>8</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-018-22395-6</pub-id><pub-id pub-id-type="pmid">29311619</pub-id></mixed-citation></ref><ref id="cit0010"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Toledo</surname>
<given-names>LG</given-names></string-name>, <string-name><surname>Ramos</surname>
<given-names>MAS</given-names></string-name>, <string-name><surname>Sp&#x000f3;sito</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Essential Oil of Cymbopogon nardus (L.) Rendle: a strategy to combat fungal infections caused by Candida species</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2016</year>;<volume>17</volume>(<issue>8</issue>):<fpage>1</fpage>&#x02013;<lpage>16</lpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms17081252</pub-id></mixed-citation></ref><ref id="cit0011"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Ghosh</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Saranya</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mukherjee</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Chandrasekaran</surname>
<given-names>N</given-names></string-name>. <article-title>Antibacterial microemulsion prevents sepsis and triggers healing of wound in wistar rats</article-title>. <source><italic toggle="yes">Colloids Surfaces B Biointerfaces</italic></source>. <year>2013</year>;<volume>105</volume>:<fpage>152</fpage>&#x02013;<lpage>157</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.colsurfb.2013.01.009</pub-id><pub-id pub-id-type="pmid">23357738</pub-id></mixed-citation></ref><ref id="cit0012"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Ramos</surname>
<given-names>MAS</given-names></string-name>, <string-name><surname>Silva</surname>
<given-names>PB</given-names></string-name>, <string-name><surname>Sp&#x000f3;sito</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Nanotechnology-based drug delivery systems for control of microbial biofilms: a review</article-title>. <source><italic toggle="yes">Int J Nanomedicine</italic></source>. <year>2018</year>;<volume>13</volume>:<fpage>1179</fpage>&#x02013;<lpage>1213</lpage>. doi:<pub-id pub-id-type="doi">10.2147/IJN.S146195</pub-id><pub-id pub-id-type="pmid">29520143</pub-id></mixed-citation></ref><ref id="cit0013"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Muzaffar</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>UK</given-names></string-name>, <string-name><surname>Chauhan</surname>
<given-names>L</given-names></string-name>. <article-title>Review on microemulsion as futuristic drug delivery</article-title>. <source><italic toggle="yes">Int J Pharm Pharm Sci</italic></source>. <year>2013</year>;<volume>5</volume>(<issue>3</issue>):<fpage>39</fpage>&#x02013;<lpage>53</lpage>.</mixed-citation></ref><ref id="cit0014"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Dos Santos Ramos</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>de Toledo</surname>
<given-names>LG</given-names></string-name>, <string-name><surname>Fioramonti Calixto</surname>
<given-names>GM</given-names></string-name>, et al. <article-title>Syngonanthus nitens Bong. (Rhul.)-loaded nanostructured system for Vulvovaginal candidiasis treatment</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2016</year>;<volume>17</volume>(<issue>8</issue>):<fpage>1368</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms17081368</pub-id></mixed-citation></ref><ref id="cit0015"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Rodero</surname>
<given-names>CF</given-names></string-name>, <string-name><surname>Fioramonti Calixto</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Cristina Dos Santos</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Curcumin-loaded liquid crystalline systems for controlled drug release and improved treatment of vulvovaginal candidiasis</article-title>. <source><italic toggle="yes">Mol Pharm</italic></source>. <year>2018</year>;<volume>15</volume>(<issue>10</issue>):<fpage>4491</fpage>&#x02013;<lpage>4504</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.8b00507</pub-id><pub-id pub-id-type="pmid">30184431</pub-id></mixed-citation></ref><ref id="cit0016"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Farias</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>F&#x000e1;varo</surname>
<given-names>DI</given-names></string-name>. <article-title>Vinte Anos de qu&#x000ed;mica verde: conquistas e desafios</article-title>. <source><italic toggle="yes">Quim Nova</italic></source>. <year>2011</year>;<volume>34</volume>(<issue>6</issue>):<fpage>1089</fpage>&#x02013;<lpage>1093</lpage>. doi:<pub-id pub-id-type="doi">10.1590/S0100-40422011000600030</pub-id></mixed-citation></ref><ref id="cit0017"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Prado</surname>
<given-names>AGS</given-names></string-name>. <article-title>Qu&#x000ed;mica verde, os desafios da qu&#x000ed;mica do novo mil&#x000ea;nio</article-title>. <source><italic toggle="yes">Quim Nova</italic></source>. <year>2003</year>;<volume>26</volume>(<issue>5</issue>):<fpage>738</fpage>&#x02013;<lpage>744</lpage>. doi:<pub-id pub-id-type="doi">10.1590/S0100-40422003000500018</pub-id></mixed-citation></ref><ref id="cit0018"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Paroul</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Grzegozeski</surname>
<given-names>LP</given-names></string-name>, <string-name><surname>Chiaradia</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Treichel</surname>
<given-names>H</given-names></string-name>. <article-title>Solvent-free production of bioflavors by enzymatic esterification of citronella (Cymbopogon winterianus) essential oil</article-title>. <source><italic toggle="yes">Appl Biochem Biotechnol</italic></source>. <year>2012</year>;<volume>166</volume>:<fpage>13</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">21976151</pub-id></mixed-citation></ref><ref id="cit0019"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Chanthai</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Prachakoll</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ruangviriyachai</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Luthria</surname>
<given-names>DL</given-names></string-name>. <article-title>Influence of extraction methodologies on the analysis of five major volatile aromatic compounds of citronella grass (Cymbopogon nardus) and lemongrass (Cymbopogon citratus) grown in thailand</article-title>. <source><italic toggle="yes">J AOAC Int</italic></source>. <year>2012</year>;<volume>95</volume>(<issue>3</issue>):<fpage>763</fpage>&#x02013;<lpage>772</lpage>. doi:<pub-id pub-id-type="doi">10.5740/jaoacint.11-335</pub-id><pub-id pub-id-type="pmid">22816268</pub-id></mixed-citation></ref><ref id="cit0020"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Vandendool</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kratz</surname>
<given-names>PD</given-names></string-name>. <article-title>A generalization of the retention index system including linear temperature programmed gas-liquid partition chromatography</article-title>. <source><italic toggle="yes">J Chromatogr</italic></source>. <year>1963</year>;<volume>11</volume>(<issue>3</issue>):<fpage>463</fpage>&#x02013;<lpage>471</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0021-9673(01)80947-X</pub-id><pub-id pub-id-type="pmid">14062605</pub-id></mixed-citation></ref><ref id="cit0021"><label>21.</label><mixed-citation publication-type="book"><string-name><surname>Adams</surname>
<given-names>R</given-names></string-name>. <source><italic toggle="yes">Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry</italic></source>. <edition>5th</edition> ed. <publisher-name>Texensis Publishing</publisher-name>; <year>2007</year>.</mixed-citation></ref><ref id="cit0022"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Bonif&#x000e1;cio</surname>
<given-names>BV</given-names></string-name>, <string-name><surname>Dos Santos Ramos</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Silva</surname>
<given-names>P</given-names></string-name>. <article-title>Nanostructured lipid system as a strategy to&#x000a0;improve the anti-Candida albicans activity of&#x000a0;Astronium sp</article-title>. <source><italic toggle="yes">Int J Nanomedicine</italic></source>. <year>2015</year>;<volume>10</volume>:<fpage>5081</fpage>&#x02013;<lpage>5092</lpage>. doi:<pub-id pub-id-type="doi">10.2147/IJN.S79684</pub-id><pub-id pub-id-type="pmid">26300640</pub-id></mixed-citation></ref><ref id="cit0023"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Calixto</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Yoshii</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Rocha</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Stringhetti</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Cury</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Chorilli</surname>
<given-names>M</given-names></string-name>. <article-title>Polyacrylic acid polymers hydrogels intended to topical drug delivery: preparation and characterization</article-title>. <source><italic toggle="yes">Pharm Dev Technol</italic></source>. <year>2014</year>;<volume>7450</volume>:<fpage>1</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="cit0024"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Dos Ramos</surname>
<given-names>MAS</given-names></string-name>, <string-name><surname>da Silva</surname>
<given-names>PB</given-names></string-name>, <string-name><surname>de Toledo</surname>
<given-names>LG</given-names></string-name>, et al. <article-title>Intravaginal delivery of syngonanthus nitens (Bong.) Ruhland fraction based on a nanoemulsion system applied to vulvovaginal candidiasis treatment</article-title>. <source><italic toggle="yes">J Biomed Nanotechnol</italic></source>. <year>2019</year>;<volume>15</volume>(<issue>5</issue>):<fpage>1072</fpage>&#x02013;<lpage>1089</lpage>. doi:<pub-id pub-id-type="doi">10.1166/jbn.2019.2750</pub-id><pub-id pub-id-type="pmid">30890237</pub-id></mixed-citation></ref><ref id="cit0025"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Eloy</surname>
<given-names>JO</given-names></string-name>, <string-name><surname>Petrilli</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ribeiro</surname>
<given-names>HM</given-names></string-name>, et al. <article-title>Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy</article-title>. <source><italic toggle="yes">Colloids Surf B Biointerfaces</italic></source>. <year>2016</year>;<volume>141</volume>:<fpage>74</fpage>&#x02013;<lpage>82</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.colsurfb.2016.01.032</pub-id><pub-id pub-id-type="pmid">26836480</pub-id></mixed-citation></ref><ref id="cit0026"><label>26.</label><mixed-citation publication-type="book"><collab>Clinical and Laboratory Standards Institute (CLSI)</collab>. <source><italic toggle="yes">Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts</italic></source>. <edition>3rd</edition> ed. <publisher-loc>Wayne</publisher-loc>: <publisher-name>CLSI document M27-A3</publisher-name>; <year>2008</year>.</mixed-citation></ref><ref id="cit0027"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Duarte</surname>
<given-names>MCT</given-names></string-name>, <string-name><surname>Figueira</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Sartoratto</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Rehder</surname>
<given-names>VLG</given-names></string-name>, <string-name><surname>Delarmelina</surname>
<given-names>C</given-names></string-name>. <article-title>Anti- Candida activity of Brazilian medicinal plants</article-title>. <source><italic toggle="yes">J Ethnopharmacol</italic></source>. <year>2005</year>;<volume>97</volume>:<fpage>305</fpage>&#x02013;<lpage>311</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jep.2004.11.016</pub-id><pub-id pub-id-type="pmid">15707770</pub-id></mixed-citation></ref><ref id="cit0028"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Peixoto</surname>
<given-names>LR</given-names></string-name>, <string-name><surname>Rosalen</surname>
<given-names>PL</given-names></string-name>, <string-name><surname>Ferreira</surname>
<given-names>GLS</given-names></string-name>, et al. <article-title>Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp</article-title>. <source><italic toggle="yes">Arch Oral Biol</italic></source>. <year>2017</year>;<volume>73</volume>:<fpage>179</fpage>&#x02013;<lpage>185</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.archoralbio.2016.10.013</pub-id><pub-id pub-id-type="pmid">27771586</pub-id></mixed-citation></ref><ref id="cit0029"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Page</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Page</surname>
<given-names>M</given-names></string-name>, <string-name><surname>No&#x000eb;l</surname>
<given-names>C</given-names></string-name>. <article-title>A new fluorometric assay for cytotoxicity measurements in vitro</article-title>. <source><italic toggle="yes">Int J Oncol</italic></source>. <year>1993</year>;<volume>3</volume>:<fpage>473</fpage>&#x02013;<lpage>476</lpage>.<pub-id pub-id-type="pmid">21573387</pub-id></mixed-citation></ref><ref id="cit0030"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Parra</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Yhebra</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Sardi&#x000f1;as</surname>
<given-names>IG</given-names></string-name>, <string-name><surname>Buela</surname>
<given-names>LI</given-names></string-name>. <article-title>Comparative study of the assay of Artemia salina L. and the estimate of the medium lethal dose (LD50 value) in mice, to determine oral acute toxicity of plant extracts</article-title>. <source><italic toggle="yes">Phytomedicine</italic></source>. <year>2001</year>;<volume>8</volume>(<issue>5</issue>):<fpage>395</fpage>&#x02013;<lpage>400</lpage>. doi:<pub-id pub-id-type="doi">10.1078/0944-7113-00044</pub-id><pub-id pub-id-type="pmid">11695884</pub-id></mixed-citation></ref><ref id="cit0031"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Mir&#x000f3;</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Rodr&#x000ed;guez</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Vigezzi</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Contribution of TLR2 pathway in the pathogenesis of vulvovaginal candidiasis</article-title>. <source><italic toggle="yes">Pathog Dis</italic></source>. <year>2018</year>;<volume>75</volume>(<issue>7</issue>):<fpage>1</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="cit0032"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Dewick</surname>
<given-names>PM</given-names></string-name>. <source><italic toggle="yes">Medicinal Natural Products: A Biosynthetic Approach</italic></source>. Vol. <volume>53</volume>
<year>2009</year>.</mixed-citation></ref><ref id="cit0033"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Ganjewala</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Luthra</surname>
<given-names>R</given-names></string-name>. <article-title>Essential oil biosynthesis and regulation in the genus cymbopogon</article-title>. <source><italic toggle="yes">Nat Prod Commun</italic></source>. <year>2010</year>;<volume>5</volume>(<issue>1</issue>):<fpage>163</fpage>&#x02013;<lpage>172</lpage>.<pub-id pub-id-type="pmid">20184044</pub-id></mixed-citation></ref><ref id="cit0034"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Wei</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>Wee</surname>
<given-names>W</given-names></string-name>. <article-title>Chemical composition and antimicrobial activity of Cymbopogon nardus citronella essential oil against systemic bacteria of aquatic animals</article-title>. <source><italic toggle="yes">Iran J Microbiol</italic></source>. <year>2013</year>;<volume>5</volume>(<issue>2</issue>):<fpage>147</fpage>&#x02013;<lpage>152</lpage>.<pub-id pub-id-type="pmid">23825733</pub-id></mixed-citation></ref><ref id="cit0035"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Zarshenas</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Samani</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Petramfar</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Moein</surname>
<given-names>M</given-names></string-name>. <article-title>Analysis of the essential oil components from different Carum copticumL. samples from Iran</article-title>. <source><italic toggle="yes">Pharmacognosy Res</italic></source>. <year>2013</year>;<volume>6</volume>(<issue>1</issue>):<fpage>62</fpage>. doi:<pub-id pub-id-type="doi">10.4103/0974-8490.122920</pub-id></mixed-citation></ref><ref id="cit0036"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Ghaffari</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Rahimmalek</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sabzalian</surname>
<given-names>MR</given-names></string-name>. <article-title>Variations in essential oil composition and antioxidant activity in Perovskia abrotanoides kar. collected from different regions in Iran</article-title>. <source><italic toggle="yes">Chem Biodivers</italic></source>. <year>2018</year>;<volume>15</volume>:<fpage>6</fpage>.</mixed-citation></ref><ref id="cit0037"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Kandimalla</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Kalita</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Choudhury</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Dash</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kalita</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kotoky</surname>
<given-names>J</given-names></string-name>. <article-title>Chemical composition and anti-candidiasis mediated wound healing property of Cymbopogon nardus essential oil on chronic diabetic wounds</article-title>. <source><italic toggle="yes">Front Pharmacol</italic></source>. <year>2016</year>;<volume>7</volume>:<page-range>(JUN):1&#x02013;8</page-range>. doi:<pub-id pub-id-type="doi">10.3389/fphar.2016.00198</pub-id></mixed-citation></ref><ref id="cit0038"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Nakahara</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Alzoreky</surname>
<given-names>NS</given-names></string-name>, <string-name><surname>Yoshihashi</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Nguyen</surname>
<given-names>HTT</given-names></string-name>, <string-name><surname>Trakoontivakorn</surname>
<given-names>G</given-names></string-name>. <article-title>Chemical Composition and Antifungal Activity of Essential Oil from Cymbopogon nardus (Citronella Grass)</article-title>. <source><italic toggle="yes">Japan Agric Res Q</italic></source>. <year>2003</year>;<volume>37</volume>(<issue>4</issue>):<fpage>249</fpage>&#x02013;<lpage>252</lpage>. doi:<pub-id pub-id-type="doi">10.6090/jarq.37.249</pub-id></mixed-citation></ref><ref id="cit0039"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Espina</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Somolinos</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lor&#x000e1;n</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Conchello</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Garc&#x000ed;a</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Pag&#x000e1;n</surname>
<given-names>R</given-names></string-name>. <article-title>Chemical composition of commercial citrus fruit essential oils and evaluation of their antimicrobial activity acting alone or in combined processes</article-title>. <source><italic toggle="yes">Food Control</italic></source>. <year>2011</year>;<volume>22</volume>(<issue>6</issue>):<fpage>896</fpage>&#x02013;<lpage>902</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.foodcont.2010.11.021</pub-id></mixed-citation></ref><ref id="cit0040"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Hyldgaard</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mygind</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Meyer</surname>
<given-names>RL</given-names></string-name>. <article-title>Essential oils in food preservation: mode of action, synergies, and interactions with food matrix components</article-title>. <source><italic toggle="yes">Front Microbiol</italic></source>. <year>2012</year>;<volume>3</volume>:<fpage>1</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">22275914</pub-id></mixed-citation></ref><ref id="cit0041"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Formariz</surname>
<given-names>TP</given-names></string-name>, <string-name><surname>Chiavacci</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Scarpa</surname>
<given-names>MV</given-names></string-name>, et al. <article-title>Structure and viscoelastic behavior of pharmaceutical biocompatible anionic microemulsions containing the antitumoral drug compound doxorubicin</article-title>. <source><italic toggle="yes">Colloids Surfaces B Biointerfaces</italic></source>. <year>2010</year>;<volume>77</volume>(<issue>1</issue>):<fpage>47</fpage>&#x02013;<lpage>53</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.colsurfb.2010.01.004</pub-id><pub-id pub-id-type="pmid">20133113</pub-id></mixed-citation></ref><ref id="cit0042"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Moghimipour</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Salimi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Eftekhari</surname>
<given-names>S</given-names></string-name>. <article-title>Design and characterization of microemulsion systems for naproxen</article-title>. <source><italic toggle="yes">Adv Pharm Bull</italic></source>. <year>2013</year>;<volume>3</volume>(<issue>1</issue>):<fpage>63</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">24312814</pub-id></mixed-citation></ref><ref id="cit0043"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Zalak</surname>
<given-names>BP</given-names></string-name>, <string-name><surname>Kruti</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Ankit</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Naazneen</surname>
<given-names>IS</given-names></string-name>. <article-title>of rosuvastatin calcium</article-title>. <source><italic toggle="yes">J Pharm Bioallied Sci</italic></source>. <year>2012</year>;<volume>4</volume>:<fpage>118</fpage>&#x02013;<lpage>120</lpage>. doi:<pub-id pub-id-type="doi">10.4103/0975-7406.94164</pub-id><pub-id pub-id-type="pmid">22557922</pub-id></mixed-citation></ref><ref id="cit0044"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Jantrawut</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Boonsermsukcharoen</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Thipnan</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Chaiwarit</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hwang</surname>
<given-names>K-M</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>E-S</given-names></string-name>. <article-title>Enhancement of antibacterial activity of orange oil in pectin thin film by microemulsion</article-title>. <source><italic toggle="yes">Nanomaterials</italic></source>. <year>2018</year>;<volume>8</volume>(<issue>7</issue>):<fpage>545</fpage>. doi:<pub-id pub-id-type="doi">10.3390/nano8070545</pub-id></mixed-citation></ref><ref id="cit0045"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Silva</surname>
<given-names>PB</given-names></string-name>, <string-name><surname>De Souza</surname>
<given-names>PC</given-names></string-name>, <string-name><surname>Maria</surname>
<given-names>G</given-names></string-name>, et al. <article-title>In Vitro Activity of Copper (II) complexes, loaded or unloaded into a nanostructured lipid system, against mycobacterium tuberculosis</article-title>. <source><italic toggle="yes">Int J Mol Sci Artic</italic></source>. <year>2016</year>;<volume>17</volume>:<fpage>745</fpage>&#x02013;<lpage>7557</lpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms17050745</pub-id></mixed-citation></ref><ref id="cit0046"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Koty&#x00144;ska</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Figaszewski</surname>
<given-names>ZA</given-names></string-name>. <article-title>Binding of trivalent metal ions (Al3+, In3+, La3+) with phosphatidylcholine liposomal membranes investigated by microelectrophoresis</article-title>. <source><italic toggle="yes">Eur Phys J E</italic></source>. <year>2018</year>;<volume>41</volume>:<fpage>5</fpage>. doi:<pub-id pub-id-type="doi">10.1140/epje/i2018-11679-6</pub-id><pub-id pub-id-type="pmid">29330740</pub-id></mixed-citation></ref><ref id="cit0047"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Klasczyk</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Knecht</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Lipowsky</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Dimova</surname>
<given-names>R</given-names></string-name>. <article-title>Interactions of alkali metal chlorides with phosphatidylcholine vesicles</article-title>. <source><italic toggle="yes">Langmuir</italic></source>. <year>2010</year>;<volume>26</volume>(<issue>24</issue>):<fpage>18951</fpage>&#x02013;<lpage>18958</lpage>. doi:<pub-id pub-id-type="doi">10.1021/la103631y</pub-id><pub-id pub-id-type="pmid">21114263</pub-id></mixed-citation></ref><ref id="cit0048"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>P&#x000e9;nzes</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ildik&#x000f3;</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Istv&#x000e1;n</surname>
<given-names>E</given-names></string-name>. <article-title>Rheological analysis of the structural properties effecting the percutaneous absorption and stability in pharmaceutical organogels</article-title>. <source><italic toggle="yes">Rheol Acta</italic></source>. <year>2004</year>;<volume>43</volume>:<fpage>457</fpage>&#x02013;<lpage>463</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00397-004-0396-1</pub-id></mixed-citation></ref><ref id="cit0049"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Carvalho</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Barbi</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Hugo</surname>
<given-names>V</given-names></string-name>, et al. <article-title>Surfactant systems for nasal zidovudine delivery: structural, rheological and mucoadhesive properties</article-title>. <source><italic toggle="yes">J Pharm Pharmacol</italic></source>. <year>2010</year>;<fpage>430</fpage>&#x02013;<lpage>439</lpage>.<pub-id pub-id-type="pmid">20604831</pub-id></mixed-citation></ref><ref id="cit0050"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Sanz</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Clares</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Mallandrich</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Su&#x000f1;er-carb&#x000f3;</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jes&#x000fa;s</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Calpena</surname>
<given-names>AC</given-names></string-name>. <article-title>Development of a mucoadhesive delivery system for control release of doxepin with application in vaginal pain relief associated with gynecological surgery</article-title>. <source><italic toggle="yes">Int J Pharm</italic></source>. <year>2018</year>;<volume>535</volume>(<issue>1&#x02013;2</issue>):<fpage>393</fpage>&#x02013;<lpage>401</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijpharm.2017.11.027</pub-id><pub-id pub-id-type="pmid">29146542</pub-id></mixed-citation></ref><ref id="cit0051"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Salmazi</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Calixto</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Bernegossi</surname>
<given-names>J</given-names></string-name>, et al. <article-title>A curcumin-loaded liquid crystal precursor mucoadhesive system for the treatment of vaginal candidiasis</article-title>. <source><italic toggle="yes">Int J Nanomedicine</italic></source>. <year>2015</year>;<volume>10</volume>:<fpage>4815</fpage>&#x02013;<lpage>4824</lpage>.<pub-id pub-id-type="pmid">26257519</pub-id></mixed-citation></ref><ref id="cit0052"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Soriano-ruiz</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Su&#x000f1;er-carb&#x000f3;</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Calpena-campmany</surname>
<given-names>AC</given-names></string-name>, et al. <article-title>Clotrimazole multiple W/O/W emulsion as anticandidal agent: characterization and evaluation on skin and mucosae</article-title>. <source><italic toggle="yes">Colloids Surfaces B Biointerfaces</italic></source>. <year>2019</year>;<volume>175</volume>:<fpage>166</fpage>&#x02013;<lpage>174</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.colsurfb.2018.11.070</pub-id><pub-id pub-id-type="pmid">30530002</pub-id></mixed-citation></ref><ref id="cit0053"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Rencber</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ay</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Katip</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Universitesi</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Limoncu</surname>
<given-names>MH</given-names></string-name>. <article-title>Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation</article-title>. <source><italic toggle="yes">Pharm Dev Technol</italic></source>. <year>2016</year>;<fpage>1</fpage>&#x02013;<lpage>11</lpage>.</mixed-citation></ref><ref id="cit0054"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Oliveira</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Gouv&#x000ea;a</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Antunes</surname>
<given-names>GR</given-names></string-name>, <string-name><surname>de Freitas</surname>
<given-names>ZMF</given-names></string-name>, <string-name><surname>Marques</surname>
<given-names>FFC</given-names></string-name>, <string-name><surname>Ricci-Junior</surname>
<given-names>E</given-names></string-name>. <article-title>Nanoemulsion containing 8-methoxypsoralen for topical treatment of dermatoses: development, characterization and ex vivo permeation in porcine skin</article-title>. <source><italic toggle="yes">Int J Pharm</italic></source>. <year>2018</year>;<volume>547</volume>(<issue>1&#x02013;2</issue>):<fpage>1</fpage>&#x02013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijpharm.2018.05.053</pub-id><pub-id pub-id-type="pmid">29800737</pub-id></mixed-citation></ref><ref id="cit0055"><label>55.</label><mixed-citation publication-type="journal"><collab>Malik S, Santos L, Mesquita S De, Silva CR. Chemical Profile and</collab>. <article-title>Biological activities of essential oil from artemisia vulgaris L. cultivated in Brazil</article-title>. <source><italic toggle="yes">Pharmaceuticals</italic></source>. <year>2019</year>;<volume>12</volume>(<issue>49</issue>):<fpage>1</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="cit0056"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Bona</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Cantamessa</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pavan</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Sensitivity of Candida albicans to essential oils: are they an alternative to antifungal agents?</article-title>
<source><italic toggle="yes">J Appl Microbiol</italic></source>. <year>2016</year>;<volume>121</volume>:<fpage>1530</fpage>&#x02013;<lpage>1545</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jam.13282</pub-id><pub-id pub-id-type="pmid">27568869</pub-id></mixed-citation></ref><ref id="cit0057"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Rivera-ya&#x000f1;ez</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Terrazas</surname>
<given-names>LI</given-names></string-name>, <string-name><surname>Jimenez-estrada</surname>
<given-names>M</given-names></string-name>, et al. <article-title>&#x003b3; -Terpinene &#x02014; an in vitro study</article-title>. <source><italic toggle="yes">Molecules</italic></source>. <year>2017</year>;<volume>22</volume>:<fpage>2095</fpage>&#x02013;<lpage>2108</lpage>. doi:<pub-id pub-id-type="doi">10.3390/molecules22122095</pub-id></mixed-citation></ref><ref id="cit0058"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Helal</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>El-bessoumy</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Al-bataineh</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Antimicrobial efficiency of essential oils from traditional medicinal plants of asir region, saudi arabia, over drug resistant isolates</article-title>. <source><italic toggle="yes">Biomed Res Int</italic></source>. <year>2019</year>;<volume>2019</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1155/2019/8928306</pub-id></mixed-citation></ref><ref id="cit0059"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Khosravi</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Sharifzadeh</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nikaein</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Almaie</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Nasrabadi</surname>
<given-names>HG</given-names></string-name>. <article-title>Chemical composition, antioxidant activity and antifungal effects of five Iranian essential oils against Candida strains isolated from urine samples</article-title>. <source><italic toggle="yes">J Mycol Med</italic></source>. <year>2018</year>;<volume>28</volume>(<issue>2</issue>):<fpage>355</fpage>&#x02013;<lpage>360</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mycmed.2018.01.005</pub-id><pub-id pub-id-type="pmid">29477783</pub-id></mixed-citation></ref><ref id="cit0060"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Trindade</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>de Ara&#x000fa;jo Oliveira</surname>
<given-names>J</given-names></string-name>, <string-name><surname>de Castro</surname>
<given-names>RD</given-names></string-name>. <article-title>de Oliveira Lima E. Inhibition of adherence of C. albicans to dental implants and cover screws by Cymbopogon nardus essential oil and citronellal</article-title>. <source><italic toggle="yes">Clin Oral Investig</italic></source>. <year>2015</year>;<volume>19</volume>(<issue>9</issue>):<fpage>2223</fpage>&#x02013;<lpage>2231</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00784-015-1450-3</pub-id></mixed-citation></ref><ref id="cit0061"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Ramos</surname>
<given-names>MAS</given-names></string-name>, <string-name><surname>Calixto</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Toledo</surname>
<given-names>LG</given-names></string-name>. et al. <article-title>Liquid crystal precursor mucoadhesive system as a strategy to improve the prophylactic action of Syngonanthus nitens (Bong.) Ruhland against infection by Candida krusei</article-title>. <source><italic toggle="yes">Int J Nanomedicine</italic></source>;<year>2015</year>
<fpage>7455</fpage>. doi:<pub-id pub-id-type="doi">10.2147/IJN.S92638</pub-id><pub-id pub-id-type="pmid">26719688</pub-id></mixed-citation></ref><ref id="cit0062"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Joe</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Bradeeba</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Parthasarathi</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Development of surfactin based nanoemulsion formulation from selected cooking oils: evaluation for antimicrobial activity against selected food associated microorganisms</article-title>. <source><italic toggle="yes">J Taiwan Inst Chem Eng</italic></source>. <year>2012</year>;<volume>43</volume>(<issue>2</issue>):<fpage>172</fpage>&#x02013;<lpage>180</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jtice.2011.08.008</pub-id></mixed-citation></ref><ref id="cit0063"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Chang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Mclandsborough</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Mcclements</surname>
<given-names>DJ</given-names></string-name>. <article-title>Physicochemical properties and antimicrobial efficacy of carvacrol nanoemulsions formed by spontaneous emulsification</article-title>. <source><italic toggle="yes">J Agric Food Chem</italic></source>. <year>2013</year>;<volume>61</volume>:<fpage>8906</fpage>&#x02013;<lpage>8913</lpage>. doi:<pub-id pub-id-type="doi">10.1021/jf402147p</pub-id><pub-id pub-id-type="pmid">23998790</pub-id></mixed-citation></ref><ref id="cit0064"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Carbone</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Musumeci</surname>
<given-names>T</given-names></string-name>. <article-title>Clotrimazole-loaded mediterranean essential oils NLC: a synergic treatment of Candida skin infections</article-title>. <source><italic toggle="yes">Pharmaceutics</italic></source>. <year>2019</year>;<volume>11</volume>:<fpage>231</fpage>&#x02013;<lpage>252</lpage>. doi:<pub-id pub-id-type="doi">10.3390/pharmaceutics11050231</pub-id></mixed-citation></ref><ref id="cit0065"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Pang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Oil Using macroporous resin followed by microemulsion encapsulation to improve its safety and antiviral activity</article-title>. <source><italic toggle="yes">Molecules</italic></source>. <year>2017</year>;<volume>22</volume>:<fpage>1</fpage>&#x02013;<lpage>16</lpage>. doi:<pub-id pub-id-type="doi">10.3390/molecules22020293</pub-id></mixed-citation></ref><ref id="cit0066"><label>66.</label><mixed-citation publication-type="journal"><string-name><surname>de Mota</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>de Oliveira Pereira</surname>
<given-names>F</given-names></string-name>, <string-name><surname>de Oliveira</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Lima</surname>
<given-names>I</given-names></string-name>, <string-name><surname>de Oliveira Lima</surname>
<given-names>E</given-names></string-name>. <article-title>Antifungal activity of thymus vulgaris l. essential oil and its constituent phytochemicals against rhizopus oryzae: interaction with ergosterol</article-title>. <source><italic toggle="yes">Molecules</italic></source>. <year>2012</year>;<volume>17</volume>(<issue>12</issue>):<fpage>14418</fpage>&#x02013;<lpage>14433</lpage>. doi:<pub-id pub-id-type="doi">10.3390/molecules171214418</pub-id><pub-id pub-id-type="pmid">23519243</pub-id></mixed-citation></ref><ref id="cit0067"><label>67.</label><mixed-citation publication-type="journal"><string-name><surname>Koba</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sanda</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Guyon</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Raynaud</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Chaumont</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Nicod</surname>
<given-names>L</given-names></string-name>. <article-title>In vitro cytotoxic activity of Cymbopogon citratus L. and Cymbopogon nardus L. essential oils from Togo</article-title>. <source><italic toggle="yes">Bangladesh J Pharmacol</italic></source>. <year>2009</year>;<volume>4</volume>(<issue>1</issue>):<fpage>29</fpage>&#x02013;<lpage>34</lpage>.</mixed-citation></ref><ref id="cit0068"><label>68.</label><mixed-citation publication-type="journal"><string-name><surname>Mcpherson</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Pharm</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Cimino</surname>
<given-names>NM</given-names></string-name>, <string-name><surname>Pharm</surname>
<given-names>D</given-names></string-name>. <article-title>Topical NSAID formulations</article-title>. <source><italic toggle="yes">Pain Med</italic></source>. <year>2013</year>;<volume>14</volume>:<fpage>35</fpage>&#x02013;<lpage>39</lpage>. doi:<pub-id pub-id-type="doi">10.1111/pme.12288</pub-id></mixed-citation></ref><ref id="cit0069"><label>69.</label><mixed-citation publication-type="journal"><string-name><surname>Radulovi&#x00107;</surname>
<given-names>NS</given-names></string-name>, <string-name><surname>Mladenovi&#x00107;</surname>
<given-names>MZ</given-names></string-name>, <string-name><surname>Blagojevi&#x00107;</surname>
<given-names>PD</given-names></string-name>, et al. <article-title>Toxic essential oils. Part III: identification and biological activity of new allylmethoxyphenyl esters from a Chamomile species (Anthemis segetalis Ten.)</article-title>. <source><italic toggle="yes">Food Chem Toxicol</italic></source>. <year>2013</year>;<volume>62</volume>:<fpage>554</fpage>&#x02013;<lpage>565</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.fct.2013.09.017</pub-id><pub-id pub-id-type="pmid">24055768</pub-id></mixed-citation></ref><ref id="cit0070"><label>70.</label><mixed-citation publication-type="journal"><string-name><surname>Martins</surname>
<given-names>MDR</given-names></string-name>, <string-name><surname>Arantes</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Candeias</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Tinoco</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Cruz-Morais</surname>
<given-names>J</given-names></string-name>. <article-title>Antioxidant, antimicrobial and toxicological properties of Schinus molle L. essential oils</article-title>. <source><italic toggle="yes">J Ethnopharmacol</italic></source>. <year>2014</year>;<volume>151</volume>(<issue>1</issue>):<fpage>485</fpage>&#x02013;<lpage>492</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jep.2013.10.063</pub-id><pub-id pub-id-type="pmid">24231069</pub-id></mixed-citation></ref><ref id="cit0071"><label>71.</label><mixed-citation publication-type="journal"><string-name><surname>Da Silva Ramos</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Rodrigues</surname>
<given-names>ABL</given-names></string-name>, <string-name><surname>Farias</surname>
<given-names>ALF</given-names></string-name>, et al. <article-title>Chemical composition and in vitro antioxidant, cytotoxic, antimicrobial, and larvicidal activities of the essential oil of mentha piperita L. (Lamiaceae)</article-title>. <source><italic toggle="yes">Sci World J</italic></source>. <year>2017</year>;<fpage>2017</fpage>.</mixed-citation></ref><ref id="cit0072"><label>72.</label><mixed-citation publication-type="journal"><string-name><surname>D&#x000e9;ciga-Campos</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rivero-Cruz</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Arriaga-Alba</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gabriela Casta&#x000f1;eda-Corral</surname>
<given-names>GE</given-names></string-name>, <string-name><surname>Angeles-L&#x000f3;pez</surname>
<given-names>AN</given-names></string-name>, <string-name><surname>Mata</surname>
<given-names>R</given-names></string-name>. <article-title>Acute toxicity and mutagenic activity of Mexican plants used in traditional medicine</article-title>. <source><italic toggle="yes">J Ethnopharmacol</italic></source>. <year>2007</year>;<volume>110</volume>:<fpage>334</fpage>&#x02013;<lpage>342</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jep.2006.10.001</pub-id><pub-id pub-id-type="pmid">17101253</pub-id></mixed-citation></ref><ref id="cit0073"><label>73.</label><mixed-citation publication-type="journal"><string-name><surname>Chamilos</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Lionakis</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Lewis</surname>
<given-names>RE</given-names></string-name>, <string-name><surname>Kontoyiannis</surname>
<given-names>DP</given-names></string-name>. <article-title>Role of mini-host models in the study of medically important fungi</article-title>. <source><italic toggle="yes">Lancet Infect Dis</italic></source>. <year>2007</year>;<volume>7</volume>(<issue>1</issue>):<fpage>42</fpage>&#x02013;<lpage>55</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1473-3099(06)70686-7</pub-id><pub-id pub-id-type="pmid">17182343</pub-id></mixed-citation></ref><ref id="cit0074"><label>74.</label><mixed-citation publication-type="journal"><string-name><surname>Break</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Jaeger</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Solis</surname>
<given-names>NV</given-names></string-name>, et al. <article-title>CX 3 CR1 Is dispensable for control of mucosal Candida albicans infections in mice and humans</article-title>. <source><italic toggle="yes">Infect Immun</italic></source>. <year>2015</year>;<volume>83</volume>(<issue>3</issue>):<fpage>958</fpage>&#x02013;<lpage>965</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.02604-14</pub-id><pub-id pub-id-type="pmid">25547797</pub-id></mixed-citation></ref><ref id="cit0075"><label>75.</label><mixed-citation publication-type="journal"><string-name><surname>Fran&#x000e7;a</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Ferreira</surname>
<given-names>LR</given-names></string-name>, <string-name><surname>Prates</surname>
<given-names>RA</given-names></string-name>, et al. <article-title>Antimicrobial photodynamic therapy as a new approach for the treatment of vulvovaginal candidiasis: preliminary results</article-title>. <source><italic toggle="yes">Lasers Med Sci</italic></source>. <year>2018</year>;<volume>33</volume>(<issue>9</issue>):<fpage>1925</fpage>&#x02013;<lpage>1931</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10103-018-2557-y</pub-id><pub-id pub-id-type="pmid">29931589</pub-id></mixed-citation></ref><ref id="cit0076"><label>76.</label><mixed-citation publication-type="journal"><string-name><surname>Pietrella</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Angiolella</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Vavala</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Beneficial effect of Mentha suaveolens essential oil in the treatment of vaginal candidiasis assessed by real-time monitoring of infection</article-title>. <source><italic toggle="yes">BMC Complement Altern Med</italic></source>. <year>2011</year>;<volume>11</volume>(<issue>1</issue>):<fpage>18</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1472-6882-11-18</pub-id><pub-id pub-id-type="pmid">21356078</pub-id></mixed-citation></ref><ref id="cit0077"><label>77.</label><mixed-citation publication-type="journal"><string-name><surname>Ahmad</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Alam</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Shehbaz</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis</article-title>. <source><italic toggle="yes">J Drug Target</italic></source>. <year>2005</year>;<volume>13</volume>(<issue>10</issue>):<fpage>555</fpage>&#x02013;<lpage>561</lpage>. doi:<pub-id pub-id-type="doi">10.1080/10611860500422958</pub-id><pub-id pub-id-type="pmid">16390816</pub-id></mixed-citation></ref></ref-list></back></article>